Tcng

TCNG The Cancer Network Galaxy0.14

Database of Cancer Gene Networks from Public Gene Expression Data

Browse Networks

GSE14095_top8000 - GSE14095 - SiGN-BN NNSRGene expression signature and the prediction of liver metastasis in colorectal cancer by DNA microarray
GSE10063_top8000 - GSE10063 - SiGN-BN NNSREffects of tobacco smoke on gene expression and cellular pathways in a cellular model of oral leukoplakia
GSE10072_top8000 - GSE10072 - SiGN-BN NNSRGene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival
GSE10138_top8000 - GSE10138 - SiGN-BN NNSRA Genomic Approach to Improve Prognosis and Predict Therapeutic Response in Chronic Lymphocytic Leukemia (Duke_VA)
GSE10245_top8000 - GSE10245 - SiGN-BN NNSRGene expression differences between adenocarcinoma and squamous cell carcinoma in human NSCLC
GSE10320_top8000 - GSE10320 - SiGN-BN NNSRPredicting Relapse in Favorable Histology Wilms Tumor Using Gene Expression
GSE10327_top8000 - GSE10327 - SiGN-BN NNSRmRNA expression data of 62 human medulloblastoma tumors
GSE10358_top8000 - GSE10358 - SiGN-BN NNSRDiscovery and validation of expression data for the Genomics of Acute Myeloid Leukemia Program at Washington University.
GSE10445_top8000 - GSE10445 - SiGN-BN NNSRMERLION LUNG CANCER STUDY
GSE10780_top8000 - GSE10780 - SiGN-BN NNSRProliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue
GSE10797_top8000 - GSE10797 - SiGN-BN NNSRTranscriptomes of breast epithelium and stroma in normal reduction mammoplasty and invasive breast cancer patients.
GSE10810_top8000 - GSE10810 - SiGN-BN NNSRGene expression signatures in breast cancer distinguish phenotype charact., histological subtypes, and tumor invasivness
GSE10843_top8000 - GSE10843 - SiGN-BN NNSRmRNA Cancer Cell Line Profiles
GSE10890_top8000 - GSE10890 - SiGN-BN NNSRmRNA Breast Cancer Cell Line Profiles
GSE10927_top8000 - GSE10927 - SiGN-BN NNSRHuman adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10), on Affymetrix HG_U133_plus_2 arrays
GSE10972_top8000 - GSE10972 - SiGN-BN NNSRColon cancer
GSE11121_top8000 - GSE11121 - SiGN-BN NNSRThe humoral immune system has a key prognostic impact in node-negative breast cancer
GSE11135_top8000 - GSE11135 - SiGN-BN NNSRThe MILE (Microarray Innovations In LEukemia) study pre-phase
GSE11151_top8000 - GSE11151 - SiGN-BN NNSRGene expression data from different types of renal tumors and normal kidneys
GSE11482_top8000 - GSE11482 - SiGN-BN NNSRRhabdoid Tumor: Gene Expression Clues to Pathogenesis and Potential Therapeutic Targets
GSE11582_top8000 - GSE11582 - SiGN-BN NNSRGenetic Analysis of Human Traits In-Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines
GSE11729_top8000 - GSE11729 - SiGN-BN NNSRH1299 EGF and Iressa stimulation
GSE11869_top8000 - GSE11869 - SiGN-BN NNSRThe genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol.
GSE12093_top8000 - GSE12093 - SiGN-BN NNSRThe 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy
GSE12195_top8000 - GSE12195 - SiGN-BN NNSRMutations of multiple genes deregulate the NF-kB pathway in diffuse large B cell lymphoma
GSE12276_top8000 - GSE12276 - SiGN-BN NNSRExpression data from primary breast tumors
GSE12391_top8000 - GSE12391 - SiGN-BN NNSRMelanoma: comparison between common nevi, radial/vertical growth phase melanoma, metastases and dysplastic nevi
GSE12428_top8000 - GSE12428 - SiGN-BN NNSRCurrent smoking-specific gene expression signature in bronchial epithelium is enhanced in squamous cell lung cancer
GSE12453_top8000 - GSE12453 - SiGN-BN NNSROrigin and pathogenesis of lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis
GSE12460_top8000 - GSE12460 - SiGN-BN NNSRExpression profiling of neuroblastic tumors
GSE12470_top8000 - GSE12470 - SiGN-BN NNSRGene expression profiles of serous ovarian cancer samples
GSE12472_top8000 - GSE12472 - SiGN-BN NNSRA COPD-related gene expression signature in squamous cell lung cancer
GSE12622_top8000 - GSE12622 - SiGN-BN NNSRTumor-associated stroma derived from primary clinical breast cancer samples (II)
GSE12627_top8000 - GSE12627 - SiGN-BN NNSRNon-supervised hierarchical clustering of gene expression data
GSE12667_top8000 - GSE12667 - SiGN-BN NNSRDiscovery of somatic mutations in lung adenocarcinomas
GSE12682_top8000 - GSE12682 - SiGN-BN NNSRExpression data from Human Kidney (HK) samples
GSE12777_top8000 - GSE12777 - SiGN-BN NNSRGene expression profiling of 51 human breast cancer cell lines
GSE12790_top8000 - GSE12790 - SiGN-BN NNSRGene expression profiling of human breast cancers and cancer cell lines
GSE12945_top8000 - GSE12945 - SiGN-BN NNSRExpression data from colorectal cancers
GSE13009_top8000 - GSE13009 - SiGN-BN NNSRMCF7 EGF, HRG stimulation
GSE13067_top8000 - GSE13067 - SiGN-BN NNSRExpression data from primary colorectal cancers
GSE13168_top8000 - GSE13168 - SiGN-BN NNSREffects of glucocorticoids and Protein Kinase A on growth factor- and 1beta- regulated gene
GSE13255_top8000 - GSE13255 - SiGN-BN NNSRGene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients with NonSmall Cell Lung Cancer.
GSE13294_top8000 - GSE13294 - SiGN-BN NNSRExpression data from primary colorectal cancers
GSE13507_top8000 - GSE13507 - SiGN-BN NNSRPredective Value of Prognosis-Related Gene Expression Study in Primary Bladder Cancer
GSE13591_top8000 - GSE13591 - SiGN-BN NNSRIntegrated genomics approach to detect allelic imbalances in multiple myeloma
GSE13598_top8000 - GSE13598 - SiGN-BN NNSRmRNA expression of 131 cancer cell lines
GSE13601_top8000 - GSE13601 - SiGN-BN NNSROral tongue cancer gene expression profiling: Identification of novel potential prognosticators
GSE13861_top8000 - GSE13861 - SiGN-BN NNSRGene expression signature-based novel prognostic risk score in gastric cancer
GSE13898_top8000 - GSE13898 - SiGN-BN NNSRRobust prognostic biomarkers for EAC identified by systems-level characterization of tumor transcriptome
GSE13911_top8000 - GSE13911 - SiGN-BN NNSRExpression data from primary gastric tumors (MSI and MSS) and adjacent normal samples
GSE13996_top8000 - GSE13996 - SiGN-BN NNSRMolecular profiling of classical Hodgkin’s lymphoma tissues
GSE14206_top8000 - GSE14206 - SiGN-BN NNSRAnalysis of ETS gene expression patterns uncovers novel ETS mediated gene silencing pathways in prostate cancers
GSE14208_top8000 - GSE14208 - SiGN-BN NNSRClinical response of metastatic gastric cancer patients to cisplatin and fluorouracil (CF) combination chemotherapy
GSE14210_top8000 - GSE14210 - SiGN-BN NNSRExpression data from human endoscopic biopsy samples
GSE14315_top8000 - GSE14315 - SiGN-BN NNSREffects of demethylation on lung cancer cell lines
GSE14333_top8000 - GSE14333 - SiGN-BN NNSRExpression data from 290 primary colorectal cancers
GSE14764_top8000 - GSE14764 - SiGN-BN NNSRA Prognostic Gene Expression Index in Ovarian Cancer
GSE14786_top8000 - GSE14786 - SiGN-BN NNSRGene expression analysis of cancer-related fatigue in whole blood from breast cancer survivors
GSE14814_top8000 - GSE14814 - SiGN-BN NNSRPrognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer
GSE14879_top8000 - GSE14879 - SiGN-BN NNSRGene expression study of anaplastic large cell lymphomas: cellular origin, pathogenesis and relation to Hodgkin lymphoma
GSE14925_top8000 - GSE14925 - SiGN-BN NNSRExpression data from Non small cell lung cancer cell lines
GSE15212_top8000 - GSE15212 - SiGN-BN NNSRIdentification and validation of NOL5A and RPS2 as potential therapeutic targtes in colorectal cancer
GSE15329_top8000 - GSE15329 - SiGN-BN NNSRGene expression profiling of human non-Hodgkins lymphoma (NHL) cell lines
GSE15395_top8000 - GSE15395 - SiGN-BN NNSRHCT116 tumor cells treated with a CDK inhibitor
GSE15396_top8000 - GSE15396 - SiGN-BN NNSRPeripheral blood mononuclear, DU145, and HCT116 cells treated with a CDK inhibitor
GSE15459_top8000 - GSE15459 - SiGN-BN NNSRGastric Cancer Project '08 (Singapore Patient Cohort)
GSE15471_top8000 - GSE15471 - SiGN-BN NNSRWhole-Tissue Gene Expression Study of Pancreatic Ductal Adenocarcinoma
GSE15641_top8000 - GSE15641 - SiGN-BN NNSRGene signatures of progression and metastasis in renal cell cancer
GSE15765_top8000 - GSE15765 - SiGN-BN NNSRIdentification of cholangiocarcinoma-like gene expression traits in hepatocellular carcinoma
GSE15852_top8000 - GSE15852 - SiGN-BN NNSRExpression data from human breast tumors and their paired normal tissues
GSE15966_top8000 - GSE15966 - SiGN-BN NNSRGene expression signature predictive of rapid response to imatinib mesylate in Gastrointestinal Stromal Tumor (GIST)
GSE16120_top8000 - GSE16120 - SiGN-BN NNSRGene profiling, mutations and expression of epidermal growth factor receptor in androgen-dependent prostate cancer
GSE16237_top8000 - GSE16237 - SiGN-BN NNSRExpression data of human neuroblastoma tissue samples
GSE16382_top8000 - GSE16382 - SiGN-BN NNSRExpression data from complex genetic sarcomas
GSE16391_top8000 - GSE16391 - SiGN-BN NNSRGGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial
GSE16446_top8000 - GSE16446 - SiGN-BN NNSRPredicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial
GSE16455_top8000 - GSE16455 - SiGN-BN NNSRIndolent MCL identified by genomic and gene expression profiling
GSE16515_top8000 - GSE16515 - SiGN-BN NNSRExpression data from Mayo Clinic Pancreatic Tumor and Normal samples
GSE16581_top8000 - GSE16581 - SiGN-BN NNSRGenomic landscape of meningiomas: gene expression
GSE16757_top8000 - GSE16757 - SiGN-BN NNSRGene expression study in hepatocellular carcinoma
GSE16987_top8000 - GSE16987 - SiGN-BN NNSRA new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis
GSE17372_top8000 - GSE17372 - SiGN-BN NNSRMolecular Classification of AIDS-Related Lymphomas [including third-party data]
GSE17536_top8000 - GSE17536 - SiGN-BN NNSRMetastasis Gene Expression Profile Predicts Recurrence and Death in Colon Cancer Patients (Moffitt Samples)
GSE17537_top8000 - GSE17537 - SiGN-BN NNSRMetastasis Gene Expression Profile Predicts Recurrence and Death in Colon Cancer Patients (VMC Samples)
GSE17705_top8000 - GSE17705 - SiGN-BN NNSREndocrine Sensitivity Index Validation Dataset
GSE17764_top8000 - GSE17764 - SiGN-BN NNSRExpression profiles associated with BRCA1 and BRCA2 mutation status in familial breast cancer patients
GSE17913_top8000 - GSE17913 - SiGN-BN NNSREffects of Cigarette Smoke on the Human Oral Mucosal Transcriptome
GSE17920_top8000 - GSE17920 - SiGN-BN NNSRExpression data of diagnostic biopsy samples from Hodgkin lymphoma patients
GSE17951_top8000 - GSE17951 - SiGN-BN NNSRGene expression analysis of prostate cancer samples using Affymetrix U133Plus2 array
GSE18088_top8000 - GSE18088 - SiGN-BN NNSRCorrelation of molecular profiles and clinical outcome of stage UICC II colon cancer patients
GSE18105_top8000 - GSE18105 - SiGN-BN NNSRStage II and stage III colorectal cancer
GSE18497_top8000 - GSE18497 - SiGN-BN NNSRDiagnosis-relapse in ALL
GSE18520_top8000 - GSE18520 - SiGN-BN NNSRWhole-genome oligonucleotide expression analysis of papillary serous ovarian adenocarcinomas
GSE18521_top8000 - GSE18521 - SiGN-BN NNSRA gene signature predictive for outcome in advanced ovarian cancer identifies a novel survival factor: MAGP2
GSE18684_top8000 - GSE18684 - SiGN-BN NNSRFine mapping of androgen regulated genes in LNCaP cells
GSE18728_top8000 - GSE18728 - SiGN-BN NNSRExpression data from human breast cancers pre and post chemothrapy
GSE18842_top8000 - GSE18842 - SiGN-BN NNSRGene expression analysis of human lung cancer and control samples
GSE18864_top8000 - GSE18864 - SiGN-BN NNSRTumor expression data from neoadjuvant trial of cisplatin monotherapy in triple negative breast cancer patients
GSE19027_top8000 - GSE19027 - SiGN-BN NNSRAntioxidant response gene expression in the bronchial airway epithelial cells of smokers at risk for lung cancer
GSE19069_top8000 - GSE19069 - SiGN-BN NNSRMolecular signatures in peripheral T-cell lymphoma (PTCL)
GSE19188_top8000 - GSE19188 - SiGN-BN NNSRExpression data for early stage NSCLC
GSE19274_top8000 - GSE19274 - SiGN-BN NNSRExpression profiling in Neuroblastoma Primary tumors and Cell lines
GSE19417_top8000 - GSE19417 - SiGN-BN NNSRHuman esophageal adenocarcinomas
GSE19494_top8000 - GSE19494 - SiGN-BN NNSRSubcutaneous adipose tissue (SAT) gene expression patterns between weight control and regaining weight subjects
GSE19615_top8000 - GSE19615 - SiGN-BN NNSRIntegrated genomic and function characterization of the 8q22 gain
GSE19784_top8000 - GSE19784 - SiGN-BN NNSRGene expression profiling of multiple myeloma patients included in the HOVON65/GMMG-HD4 trial
GSE19804_top8000 - GSE19804 - SiGN-BN NNSRGenome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan
GSE20181_top8000 - GSE20181 - SiGN-BN NNSRLetrozole (Femara) early and late responses to treatment
GSE20189_top8000 - GSE20189 - SiGN-BN NNSRA gene expression signature from peripheral whole blood for stage I lung adenocarcinoma
GSE20194_top8000 - GSE20194 - SiGN-BN NNSRMAQC-II Project: human breast cancer (BR) data set
GSE20257_top8000 - GSE20257 - SiGN-BN NNSRSmoking-induced Disarray of the Apical Junctional Complex Gene Expression Architecture in the Human Airway Epithelium
GSE20271_top8000 - GSE20271 - SiGN-BN NNSRExpression data from breast cancer FNA biopsies from patients
GSE2034_top8000 - GSE2034 - SiGN-BN NNSRBreast cancer relapse free survival
GSE20685_top8000 - GSE20685 - SiGN-BN NNSRMicroarray-based molecular subtyping of breast cancer
GSE20842_top8000 - GSE20842 - SiGN-BN NNSRMutated KRAS induces overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas
GSE20916_top8000 - GSE20916 - SiGN-BN NNSRModeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data
GSE21029_top8000 - GSE21029 - SiGN-BN NNSRThe lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia (CLL)
GSE21050_top8000 - GSE21050 - SiGN-BN NNSRExpression data from Complex genetics sarcomas (cohort 1 and 2)
GSE21122_top8000 - GSE21122 - SiGN-BN NNSRWhole-transcript expression data for soft-tissue sarcoma tumors and control normal fat specimens
GSE2113_top8000 - GSE2113 - SiGN-BN NNSRPlasma cell dyscrasias expression profiles associated with distinct IGH translocations in multiple myeloma
GSE21452_top8000 - GSE21452 - SiGN-BN NNSRIntegrated genomic profiling in mantle cell lymphoma
GSE21501_top8000 - GSE21501 - SiGN-BN NNSRA six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma
GSE21510_top8000 - GSE21510 - SiGN-BN NNSRClinical Significance of Osteoprotegerin Expression in Human Colorectal Cancer
GSE21653_top8000 - GSE21653 - SiGN-BN NNSRA gene expression signature identifies two prognostic subgroups of basal breast cancer
GSE22093_top8000 - GSE22093 - SiGN-BN NNSRExpression data from breast cancer FNA biopsies from patients
GSE22138_top8000 - GSE22138 - SiGN-BN NNSRExpression Data from Uveal Melanoma primary tumors.
GSE22153_top8000 - GSE22153 - SiGN-BN NNSRGene Experssion Profiling-Based Identification of Molecular Subtypes in Stage IV Melanoma with Different Clinical Outcome (test set)
GSE22541_top8000 - GSE22541 - SiGN-BN NNSRExpression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals
GSE22597_top8000 - GSE22597 - SiGN-BN NNSRExpression data from Fine Needle Aspiration (FNA) biopsies from breast cancer patients
GSE2294_top8000 - GSE2294 - SiGN-BN NNSRA Modular Analysis of Breast Cancer Reveals a Novel Low-Grade Molecular Signature in Estrogen Receptor-Positive Tumors
GSE23036_top8000 - GSE23036 - SiGN-BN NNSRGene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma
GSE23120_top8000 - GSE23120 - SiGN-BN NNSRBasal gene expression data from Human Variation Panel
GSE23177_top8000 - GSE23177 - SiGN-BN NNSRPrediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs.
GSE23553_top8000 - GSE23553 - SiGN-BN NNSRGene expression changes with induction of in-vitro platinum-resistance in ovarian cancer cell lines.
GSE23593_top8000 - GSE23593 - SiGN-BN NNSRIntratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome
GSE23772_top8000 - GSE23772 - SiGN-BN NNSRWhy does HAMLET preferentially kill tumor cells? p38-dependent death in tumor but up-regulation of innate immunity in healthy, differentiated cells
GSE23806_top8000 - GSE23806 - SiGN-BN NNSRExpression data of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors
GSE23878_top8000 - GSE23878 - SiGN-BN NNSRGenome Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy
GSE23980_top8000 - GSE23980 - SiGN-BN NNSRExpression data from human soft tissue sarcomas with complex genomics
GSE23988_top8000 - GSE23988 - SiGN-BN NNSRExpression data from breast cancer FNA biopsies from patients (US samples)
GSE23991_top8000 - GSE23991 - SiGN-BN NNSREffect of zebularine on primary human liver cancer cell lines
GSE24080_top8000 - GSE24080 - SiGN-BN NNSRMAQC-II Project: Multiple myeloma (MM) data set
GSE24124_top8000 - GSE24124 - SiGN-BN NNSRMajor gene partners of a favorable biomarker in ER(+) breast cancer
GSE24185_top8000 - GSE24185 - SiGN-BN NNSRGene transcription signature of obesity in breast cancer
GSE25055_top8000 - GSE25055 - SiGN-BN NNSRDiscovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer
GSE25065_top8000 - GSE25065 - SiGN-BN NNSRValidation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer
GSE25066_top8000 - GSE25066 - SiGN-BN NNSRGenomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer
GSE25136_top8000 - GSE25136 - SiGN-BN NNSROptimizing molecular signatures for prostate cancer recurrence
GSE25428_top8000 - GSE25428 - SiGN-BN NNSRGene expression profiles of ovarian cancer cell lines in the presence and absence of a DNA methyltransferase inhibitor
GSE2549_top8000 - GSE2549 - SiGN-BN NNSRMalignant pleural mesothelioma
GSE2603_top8000 - GSE2603 - SiGN-BN NNSRSubpopulations of MDA-MB-231 and Primary Breast Cancers
GSE26549_top8000 - GSE26549 - SiGN-BN NNSRGene Expression Profiling Predicts the Development of Oral Cancer
GSE26599_top8000 - GSE26599 - SiGN-BN NNSRGene expression profile in response to doxorubicin-rapamycin combined treatment of HER-2 overexpressing human mammary epithelial cell lines
GSE26639_top8000 - GSE26639 - SiGN-BN NNSRExpression Data from 226 patients of the REMAGUS02 trial
GSE26712_top8000 - GSE26712 - SiGN-BN NNSRA Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer
GSE26906_top8000 - GSE26906 - SiGN-BN NNSRAPC colon stage II
GSE27155_top8000 - GSE27155 - SiGN-BN NNSRHuman thyroid adenomas, carcinomas, and normals
GSE27480_top8000 - GSE27480 - SiGN-BN NNSRGene-expression analysis of Oncostatin-M (OSM) signalling in cervical squamous cell carcinomas over-expressing the Oncostatin-M receptor (OSMR)
GSE27562_top8000 - GSE27562 - SiGN-BN NNSRExpression data from human PBMCs from breast cancer patients and controls
GSE2841_top8000 - GSE2841 - SiGN-BN NNSRExpression Profiling of pheochromocytomas of various genetic origins
GSE28497_top8000 - GSE28497 - SiGN-BN NNSRNew markers for minimal residual disease detection in acute lymphoblastic leukemia
GSE28821_top8000 - GSE28821 - SiGN-BN NNSRLaser-capture microdissected invasive micropapillary carcinomas of the breast
GSE29013_top8000 - GSE29013 - SiGN-BN NNSRRobust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non-Small-Cell Lung Cancer Patients
GSE2912_top8000 - GSE2912 - SiGN-BN NNSRMolecular classification of multiple myeloma
GSE29288_top8000 - GSE29288 - SiGN-BN NNSRComparison between cell lines from 9 different cancer tissue (NCI-60) (Agilent WG platform)
GSE29354_top8000 - GSE29354 - SiGN-BN NNSRMesothelioma tumor gene expression profiles
GSE29598_top8000 - GSE29598 - SiGN-BN NNSRA Methodology for Utilization of Predictive Genomic Signatures in FFPE Samples
GSE29683_top8000 - GSE29683 - SiGN-BN NNSRCoexpression of Normally Incompatible Developmental Pathways in Retinoblastoma Genesis [human tumor/cell line data]
GSE29817_top8000 - GSE29817 - SiGN-BN NNSRMembranous Expression of Ectodomain Isoforms of the Epidermal Growth Factor Receptor (EGFR) Predicts Outcome after Chemoradiotherapy of Lymph Node Negative Cervical Cancer
GSE2990_top8000 - GSE2990 - SiGN-BN NNSRGene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
GSE30240_top8000 - GSE30240 - SiGN-BN NNSRExpression data from 5 human cell lines exposed to IR (5 Gy)
GSE30375_top8000 - GSE30375 - SiGN-BN NNSRGene expression data from sorted and unsorted primary human acute myeloid leukemia (AML) samples
GSE30784_top8000 - GSE30784 - SiGN-BN NNSRGene expression profiling of oral squamous cell carcinoma (OSCC)
GSE30929_top8000 - GSE30929 - SiGN-BN NNSRWhole-transcript expression data for liposarcoma
GSE31245_top8000 - GSE31245 - SiGN-BN NNSRUnique gene expression profile based upon pathologic response in epithelial ovarian cancer
GSE31279_top8000 - GSE31279 - SiGN-BN NNSRDecoding differentially regulated epithelial and stromal pathways in colorectal cancer
GSE3141_top8000 - GSE3141 - SiGN-BN NNSRLung Cancer Dataset
GSE3143_top8000 - GSE3143 - SiGN-BN NNSRBreast Cancer Dataset
GSE3149_top8000 - GSE3149 - SiGN-BN NNSROvarian Cancer Dataset
GSE3151_top8000 - GSE3151 - SiGN-BN NNSROncogene Signature Dataset
GSE31519_top8000 - GSE31519 - SiGN-BN NNSRA Clinically Relevant Gene Signature in Triple-Negative and Basal-Like Breast Cancer
GSE31547_top8000 - GSE31547 - SiGN-BN NNSRMSKCC-A Primary Lung Cancer Specimens
GSE31548_top8000 - GSE31548 - SiGN-BN NNSRMSKCC-B Primary Lung Cancer Specimens
GSE31552_top8000 - GSE31552 - SiGN-BN NNSRExpression Data from human Lung tissue of Patients with Non Small Cell Lung Cancer (NSCLC)
GSE3167_top8000 - GSE3167 - SiGN-BN NNSRClassification of carcinoma in situ lesions in human bladder cancer
GSE32269_top8000 - GSE32269 - SiGN-BN NNSRExpression data for primary localized prostate cancer versus castration-resistant bone metastatic prostate cancer
GSE32448_top8000 - GSE32448 - SiGN-BN NNSRCPDR tumor-benign 80 genechip dataset
GSE32474_top8000 - GSE32474 - SiGN-BN NNSRComparison between cell lines from 9 different cancer tissue (NCI-60) (Affymetrix U133 Plus 2.0)
GSE3593_top8000 - GSE3593 - SiGN-BN NNSRGenomic approach to refine prognosis for adjuvant therapy in early stage non-small cell lung carcinoma
GSE3629_top8000 - GSE3629 - SiGN-BN NNSRMolecular Marker for predicting development of cancer in ulcerative colitis
GSE3726_top8000 - GSE3726 - SiGN-BN NNSRPrognostic gene signatures can be measured with samples stored in RNAlater
GSE3960_top8000 - GSE3960 - SiGN-BN NNSRClassification of neuroblastoma by integrating gene expression pattern with regional alterations in DNA copy number
GSE4115_top8000 - GSE4115 - SiGN-BN NNSRAirway Epithelial Gene Expression Diagnostic for the Evaluation of Smokers with Suspect Lung Cancer
GSE4122_top8000 - GSE4122 - SiGN-BN NNSRGene Expression Analysis of Ovarian Samples
GSE4183_top8000 - GSE4183 - SiGN-BN NNSRInflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature
GSE4290_top8000 - GSE4290 - SiGN-BN NNSRExpression data of glioma samples from Henry Ford Hospital
GSE4452_top8000 - GSE4452 - SiGN-BN NNSRGene Expression Profiles of Multiple Myeloma (N=65) Before Treatment
GSE4459_top8000 - GSE4459 - SiGN-BN NNSRGene expression signature and the prediction of lymph node metastases
GSE4536_top8000 - GSE4536 - SiGN-BN NNSRTumor stem cells more closely mirror the phenotype and genotype of primary human tumors than do cancer cell lines
GSE4554_top8000 - GSE4554 - SiGN-BN NNSRGene expression signature of colorectal cancer with microsatellite instability.
GSE4573_top8000 - GSE4573 - SiGN-BN NNSRGene expression signatures for predicting prognosis of squamous cell lung carcinomas
GSE4581_top8000 - GSE4581 - SiGN-BN NNSRGene Expression Profiles of Multiple Myeloma (N=414) Before Treatment
GSE4823_top8000 - GSE4823 - SiGN-BN NNSRComparison of normal breast epithelium and stroma from reduction and I.D.C. cases
GSE5107_top8000 - GSE5107 - SiGN-BN NNSRDistinct Transcription Profiles of Primary and Secondary Glioblastomas
GSE5206_top8000 - GSE5206 - SiGN-BN NNSRLarge-scale deployment of embryonic gene programming in human and murine colon cancer: a new target for intervention.
GSE5327_top8000 - GSE5327 - SiGN-BN NNSRBreast cancer relapse free survival and lung metastasis free survival
GSE5364_top8000 - GSE5364 - SiGN-BN NNSRA Precisely Regulated Gene Expression Cassette Potently Modulates Metastasis and Survival in Multiple Solid Cancers
GSE5460_top8000 - GSE5460 - SiGN-BN NNSRPredicting Features of Breast Cancer with Gene Expression Patterns
GSE5462_top8000 - GSE5462 - SiGN-BN NNSRLetrozole (Femara) early response to treatment
GSE5846_top8000 - GSE5846 - SiGN-BN NNSRNCI-60 Cancer Cell Line
GSE5847_top8000 - GSE5847 - SiGN-BN NNSRTumor and stroma from breast by LCM
GSE5851_top8000 - GSE5851 - SiGN-BN NNSRPhase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC
GSE5900_top8000 - GSE5900 - SiGN-BN NNSRGene Expression of Bone Marrow Plasma Cells from Healthy Donors (N=22), MGUS (N=44), and Smoldering Myeloma (N=12)
GSE6008_top8000 - GSE6008 - SiGN-BN NNSRHuman ovarian tumors and normal ovaries
GSE6338_top8000 - GSE6338 - SiGN-BN NNSRGene expression analysis of Peripheral T-cell Lymphoma/Unspecified
GSE6365_top8000 - GSE6365 - SiGN-BN NNSRDistinct transcriptional and genetic features associated with chromosome 13 deletion in multiple myeloma
GSE6401_top8000 - GSE6401 - SiGN-BN NNSRUp-regulation of translational machinery and distinct genetic subgroups characterize hyperdiploidy in multiple myeloma
GSE6462_top8000 - GSE6462 - SiGN-BN NNSRMCF7 dose response
GSE6465_top8000 - GSE6465 - SiGN-BN NNSRExpression data of Hepatocellular Carcinoma
GSE6477_top8000 - GSE6477 - SiGN-BN NNSRExpression data from different stages of plasma cell neoplasm
GSE6481_top8000 - GSE6481 - SiGN-BN NNSRGene Expression Analysis of Soft Tissue Sarcomas: Characterization & Reclassification of Malignant Fibrous Histiocytoma
GSE6691_top8000 - GSE6691 - SiGN-BN NNSRGene expression profiling of B lymphocytes and plasma cells from WaldenstrÖm’s macroglobulinemia.
GSE6764_top8000 - GSE6764 - SiGN-BN NNSRGenome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma
GSE6791_top8000 - GSE6791 - SiGN-BN NNSRGene Expression Profiles of HPV-Positive and -Negative Head/Neck and Cervical Cancers
GSE6956_top8000 - GSE6956 - SiGN-BN NNSRTumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men
GSE7208_top8000 - GSE7208 - SiGN-BN NNSRExpression data from 59 human colon tumor tissue samples
GSE7390_top8000 - GSE7390 - SiGN-BN NNSRStrong Time Dependence of the 76-Gene Prognostic Signature
GSE7553_top8000 - GSE7553 - SiGN-BN NNSRGene Expression Patterns Involved in the Malignant Transformation and Progression of Metastatic Melanoma
GSE7604_top8000 - GSE7604 - SiGN-BN NNSRHuman Colon tumor vs Normal Human DNA
GSE7606_top8000 - GSE7606 - SiGN-BN NNSRHuman Melanoma vs Normal Human DNA
GSE7670_top8000 - GSE7670 - SiGN-BN NNSRExpression data from Lung cancer
GSE7696_top8000 - GSE7696 - SiGN-BN NNSRGlioblastoma from a homogenous cohort of patients treated within clinical trial
GSE7849_top8000 - GSE7849 - SiGN-BN NNSRAge-Specific Differences of Oncogenic Pathway Deregulation Seen in Human Breast Tumors
GSE7904_top8000 - GSE7904 - SiGN-BN NNSRExpression data from human breast tissue
GSE8057_top8000 - GSE8057 - SiGN-BN NNSRExpression data from ovarian cancer cells with time-course and concentration-profiles
GSE8139_top8000 - GSE8139 - SiGN-BN NNSRExpression data from MCF7/HER2-18 xenografts
GSE8141_top8000 - GSE8141 - SiGN-BN NNSRExpression data from MCF7 wt and MCF7/HER2-18 xenografts
GSE8218_top8000 - GSE8218 - SiGN-BN NNSRGene expression data from prostate cancer samples
GSE8332_top8000 - GSE8332 - SiGN-BN NNSRDeath receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL
GSE8401_top8000 - GSE8401 - SiGN-BN NNSRGene Signature for Aggression of Melanoma Metastases - Melanoma Metastasis
GSE8481_top8000 - GSE8481 - SiGN-BN NNSRVarious human cell types
GSE8546_top8000 - GSE8546 - SiGN-BN NNSRGene Expression Changes in Myeloma Cells Following Short Term In-vivo Drug Exposure
GSE8581_top8000 - GSE8581 - SiGN-BN NNSRHuman Chronic Obstructive Pulmonary Disorder (COPD) Biomarker
GSE8671_top8000 - GSE8671 - SiGN-BN NNSRTranscriptome profile of human colorectal adenomas.
GSE8835_top8000 - GSE8835 - SiGN-BN NNSRChronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells.
GSE8894_top8000 - GSE8894 - SiGN-BN NNSRPrediction of Recurrence-Free Survival in Postoperative NSCLC Patients—a Useful Prospective Clinical Practice
GSE9014_top8000 - GSE9014 - SiGN-BN NNSRTumor-associated stroma derived from primary clinical breast cancer samples
GSE9169_top8000 - GSE9169 - SiGN-BN NNSRGene expression during neuronal differentiation in two subtypes of SH-SY5Y
GSE9195_top8000 - GSE9195 - SiGN-BN NNSRPredicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
GSE9309_top8000 - GSE9309 - SiGN-BN NNSRRecovery of biological information under heterogeneous experimental conditions using subgroup standardization.
GSE9348_top8000 - GSE9348 - SiGN-BN NNSRExpression data from healthy controls and early stage CRC patient's tumor
GSE9750_top8000 - GSE9750 - SiGN-BN NNSRIdentification of gene expression profiles in cervical cancer
GSE9843_top8000 - GSE9843 - SiGN-BN NNSRGene expression profiling of 91 hepatocellular carcinomas with hepatitis C virus etiology
GSE9936_top8000 - GSE9936 - SiGN-BN NNSRExpression data from human breast cancer cells (MCF-7) coexpressing ERalpha and Erbeta, treated with phytoestrogens
GSE9992_top8000 - GSE9992 - SiGN-BN NNSRMolecular and transcriptional characterization of chromosome 17p loss in chronic lymphocytic leukemia, experiment A
GSE10063_top500tf - GSE10063 - SiGN-BN HC+BootstrapEffects of tobacco smoke on gene expression and cellular pathways in a cellular model of oral leukoplakia
GSE10072_top500tf - GSE10072 - SiGN-BN HC+BootstrapGene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival
GSE10138_top500tf - GSE10138 - SiGN-BN HC+BootstrapA Genomic Approach to Improve Prognosis and Predict Therapeutic Response in Chronic Lymphocytic Leukemia (Duke_VA)
GSE10245_top500tf - GSE10245 - SiGN-BN HC+BootstrapGene expression differences between adenocarcinoma and squamous cell carcinoma in human NSCLC
GSE10320_top500tf - GSE10320 - SiGN-BN HC+BootstrapPredicting Relapse in Favorable Histology Wilms Tumor Using Gene Expression
GSE10327_top500tf - GSE10327 - SiGN-BN HC+BootstrapmRNA expression data of 62 human medulloblastoma tumors
GSE10358_top500tf - GSE10358 - SiGN-BN HC+BootstrapDiscovery and validation of expression data for the Genomics of Acute Myeloid Leukemia Program at Washington University.
GSE10445_top500tf - GSE10445 - SiGN-BN HC+BootstrapMERLION LUNG CANCER STUDY
GSE10780_top500tf - GSE10780 - SiGN-BN HC+BootstrapProliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue
GSE10797_top500tf - GSE10797 - SiGN-BN HC+BootstrapTranscriptomes of breast epithelium and stroma in normal reduction mammoplasty and invasive breast cancer patients.
GSE10810_top500tf - GSE10810 - SiGN-BN HC+BootstrapGene expression signatures in breast cancer distinguish phenotype charact., histological subtypes, and tumor invasivness
GSE10843_top500tf - GSE10843 - SiGN-BN HC+BootstrapmRNA Cancer Cell Line Profiles
GSE10890_top500tf - GSE10890 - SiGN-BN HC+BootstrapmRNA Breast Cancer Cell Line Profiles
GSE10927_top500tf - GSE10927 - SiGN-BN HC+BootstrapHuman adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10), on Affymetrix HG_U133_plus_2 arrays
GSE10972_top500tf - GSE10972 - SiGN-BN HC+BootstrapColon cancer
GSE11121_top500tf - GSE11121 - SiGN-BN HC+BootstrapThe humoral immune system has a key prognostic impact in node-negative breast cancer
GSE11135_top500tf - GSE11135 - SiGN-BN HC+BootstrapThe MILE (Microarray Innovations In LEukemia) study pre-phase
GSE11151_top500tf - GSE11151 - SiGN-BN HC+BootstrapGene expression data from different types of renal tumors and normal kidneys
GSE11482_top500tf - GSE11482 - SiGN-BN HC+BootstrapRhabdoid Tumor: Gene Expression Clues to Pathogenesis and Potential Therapeutic Targets
GSE11582_top500tf - GSE11582 - SiGN-BN HC+BootstrapGenetic Analysis of Human Traits In-Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines
GSE11729_top500tf - GSE11729 - SiGN-BN HC+BootstrapH1299 EGF and Iressa stimulation
GSE11869_top500tf - GSE11869 - SiGN-BN HC+BootstrapThe genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol.
GSE12093_top500tf - GSE12093 - SiGN-BN HC+BootstrapThe 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy
GSE12195_top500tf - GSE12195 - SiGN-BN HC+BootstrapMutations of multiple genes deregulate the NF-kB pathway in diffuse large B cell lymphoma
GSE12276_top500tf - GSE12276 - SiGN-BN HC+BootstrapExpression data from primary breast tumors
GSE12391_top500tf - GSE12391 - SiGN-BN HC+BootstrapMelanoma: comparison between common nevi, radial/vertical growth phase melanoma, metastases and dysplastic nevi
GSE12428_top500tf - GSE12428 - SiGN-BN HC+BootstrapCurrent smoking-specific gene expression signature in bronchial epithelium is enhanced in squamous cell lung cancer
GSE12453_top500tf - GSE12453 - SiGN-BN HC+BootstrapOrigin and pathogenesis of lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis
GSE12460_top500tf - GSE12460 - SiGN-BN HC+BootstrapExpression profiling of neuroblastic tumors
GSE12470_top500tf - GSE12470 - SiGN-BN HC+BootstrapGene expression profiles of serous ovarian cancer samples
GSE12472_top500tf - GSE12472 - SiGN-BN HC+BootstrapA COPD-related gene expression signature in squamous cell lung cancer
GSE12622_top500tf - GSE12622 - SiGN-BN HC+BootstrapTumor-associated stroma derived from primary clinical breast cancer samples (II)
GSE12627_top500tf - GSE12627 - SiGN-BN HC+BootstrapNon-supervised hierarchical clustering of gene expression data
GSE12667_top500tf - GSE12667 - SiGN-BN HC+BootstrapDiscovery of somatic mutations in lung adenocarcinomas
GSE12682_top500tf - GSE12682 - SiGN-BN HC+BootstrapExpression data from Human Kidney (HK) samples
GSE12777_top500tf - GSE12777 - SiGN-BN HC+BootstrapGene expression profiling of 51 human breast cancer cell lines
GSE12790_top500tf - GSE12790 - SiGN-BN HC+BootstrapGene expression profiling of human breast cancers and cancer cell lines
GSE12945_top500tf - GSE12945 - SiGN-BN HC+BootstrapExpression data from colorectal cancers
GSE13009_top500tf - GSE13009 - SiGN-BN HC+BootstrapMCF7 EGF, HRG stimulation
GSE13067_top500tf - GSE13067 - SiGN-BN HC+BootstrapExpression data from primary colorectal cancers
GSE13168_top500tf - GSE13168 - SiGN-BN HC+BootstrapEffects of glucocorticoids and Protein Kinase A on growth factor- and 1beta- regulated gene
GSE13255_top500tf - GSE13255 - SiGN-BN HC+BootstrapGene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients with NonSmall Cell Lung Cancer.
GSE13294_top500tf - GSE13294 - SiGN-BN HC+BootstrapExpression data from primary colorectal cancers
GSE13507_top500tf - GSE13507 - SiGN-BN HC+BootstrapPredective Value of Prognosis-Related Gene Expression Study in Primary Bladder Cancer
GSE13591_top500tf - GSE13591 - SiGN-BN HC+BootstrapIntegrated genomics approach to detect allelic imbalances in multiple myeloma
GSE13598_top500tf - GSE13598 - SiGN-BN HC+BootstrapmRNA expression of 131 cancer cell lines
GSE13601_top500tf - GSE13601 - SiGN-BN HC+BootstrapOral tongue cancer gene expression profiling: Identification of novel potential prognosticators
GSE13861_top500tf - GSE13861 - SiGN-BN HC+BootstrapGene expression signature-based novel prognostic risk score in gastric cancer
GSE13898_top500tf - GSE13898 - SiGN-BN HC+BootstrapRobust prognostic biomarkers for EAC identified by systems-level characterization of tumor transcriptome
GSE13911_top500tf - GSE13911 - SiGN-BN HC+BootstrapExpression data from primary gastric tumors (MSI and MSS) and adjacent normal samples
GSE13996_top500tf - GSE13996 - SiGN-BN HC+BootstrapMolecular profiling of classical Hodgkin’s lymphoma tissues
GSE14095_top500tf - GSE14095 - SiGN-BN HC+BootstrapGene expression signature and the prediction of liver metastasis in colorectal cancer by DNA microarray
GSE14206_top500tf - GSE14206 - SiGN-BN HC+BootstrapAnalysis of ETS gene expression patterns uncovers novel ETS mediated gene silencing pathways in prostate cancers
GSE14208_top500tf - GSE14208 - SiGN-BN HC+BootstrapClinical response of metastatic gastric cancer patients to cisplatin and fluorouracil (CF) combination chemotherapy
GSE14210_top500tf - GSE14210 - SiGN-BN HC+BootstrapExpression data from human endoscopic biopsy samples
GSE14315_top500tf - GSE14315 - SiGN-BN HC+BootstrapEffects of demethylation on lung cancer cell lines
GSE14333_top500tf - GSE14333 - SiGN-BN HC+BootstrapExpression data from 290 primary colorectal cancers
GSE14764_top500tf - GSE14764 - SiGN-BN HC+BootstrapA Prognostic Gene Expression Index in Ovarian Cancer
GSE14786_top500tf - GSE14786 - SiGN-BN HC+BootstrapGene expression analysis of cancer-related fatigue in whole blood from breast cancer survivors
GSE14814_top500tf - GSE14814 - SiGN-BN HC+BootstrapPrognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer
GSE14879_top500tf - GSE14879 - SiGN-BN HC+BootstrapGene expression study of anaplastic large cell lymphomas: cellular origin, pathogenesis and relation to Hodgkin lymphoma
GSE14925_top500tf - GSE14925 - SiGN-BN HC+BootstrapExpression data from Non small cell lung cancer cell lines
GSE15212_top500tf - GSE15212 - SiGN-BN HC+BootstrapIdentification and validation of NOL5A and RPS2 as potential therapeutic targtes in colorectal cancer
GSE15329_top500tf - GSE15329 - SiGN-BN HC+BootstrapGene expression profiling of human non-Hodgkins lymphoma (NHL) cell lines
GSE15395_top500tf - GSE15395 - SiGN-BN HC+BootstrapHCT116 tumor cells treated with a CDK inhibitor
GSE15396_top500tf - GSE15396 - SiGN-BN HC+BootstrapPeripheral blood mononuclear, DU145, and HCT116 cells treated with a CDK inhibitor
GSE15459_top500tf - GSE15459 - SiGN-BN HC+BootstrapGastric Cancer Project '08 (Singapore Patient Cohort)
GSE15471_top500tf - GSE15471 - SiGN-BN HC+BootstrapWhole-Tissue Gene Expression Study of Pancreatic Ductal Adenocarcinoma
GSE15641_top500tf - GSE15641 - SiGN-BN HC+BootstrapGene signatures of progression and metastasis in renal cell cancer
GSE15765_top500tf - GSE15765 - SiGN-BN HC+BootstrapIdentification of cholangiocarcinoma-like gene expression traits in hepatocellular carcinoma
GSE15852_top500tf - GSE15852 - SiGN-BN HC+BootstrapExpression data from human breast tumors and their paired normal tissues
GSE15966_top500tf - GSE15966 - SiGN-BN HC+BootstrapGene expression signature predictive of rapid response to imatinib mesylate in Gastrointestinal Stromal Tumor (GIST)
GSE16120_top500tf - GSE16120 - SiGN-BN HC+BootstrapGene profiling, mutations and expression of epidermal growth factor receptor in androgen-dependent prostate cancer
GSE16237_top500tf - GSE16237 - SiGN-BN HC+BootstrapExpression data of human neuroblastoma tissue samples
GSE16382_top500tf - GSE16382 - SiGN-BN HC+BootstrapExpression data from complex genetic sarcomas
GSE16391_top500tf - GSE16391 - SiGN-BN HC+BootstrapGGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial
GSE16446_top500tf - GSE16446 - SiGN-BN HC+BootstrapPredicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial
GSE16455_top500tf - GSE16455 - SiGN-BN HC+BootstrapIndolent MCL identified by genomic and gene expression profiling
GSE16515_top500tf - GSE16515 - SiGN-BN HC+BootstrapExpression data from Mayo Clinic Pancreatic Tumor and Normal samples
GSE16581_top500tf - GSE16581 - SiGN-BN HC+BootstrapGenomic landscape of meningiomas: gene expression
GSE16757_top500tf - GSE16757 - SiGN-BN HC+BootstrapGene expression study in hepatocellular carcinoma
GSE16987_top500tf - GSE16987 - SiGN-BN HC+BootstrapA new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis
GSE17372_top500tf - GSE17372 - SiGN-BN HC+BootstrapMolecular Classification of AIDS-Related Lymphomas [including third-party data]
GSE17536_top500tf - GSE17536 - SiGN-BN HC+BootstrapMetastasis Gene Expression Profile Predicts Recurrence and Death in Colon Cancer Patients (Moffitt Samples)
GSE17537_top500tf - GSE17537 - SiGN-BN HC+BootstrapMetastasis Gene Expression Profile Predicts Recurrence and Death in Colon Cancer Patients (VMC Samples)
GSE17705_top500tf - GSE17705 - SiGN-BN HC+BootstrapEndocrine Sensitivity Index Validation Dataset
GSE17764_top500tf - GSE17764 - SiGN-BN HC+BootstrapExpression profiles associated with BRCA1 and BRCA2 mutation status in familial breast cancer patients
GSE17913_top500tf - GSE17913 - SiGN-BN HC+BootstrapEffects of Cigarette Smoke on the Human Oral Mucosal Transcriptome
GSE17920_top500tf - GSE17920 - SiGN-BN HC+BootstrapExpression data of diagnostic biopsy samples from Hodgkin lymphoma patients
GSE17951_top500tf - GSE17951 - SiGN-BN HC+BootstrapGene expression analysis of prostate cancer samples using Affymetrix U133Plus2 array
GSE18088_top500tf - GSE18088 - SiGN-BN HC+BootstrapCorrelation of molecular profiles and clinical outcome of stage UICC II colon cancer patients
GSE18105_top500tf - GSE18105 - SiGN-BN HC+BootstrapStage II and stage III colorectal cancer
GSE18497_top500tf - GSE18497 - SiGN-BN HC+BootstrapDiagnosis-relapse in ALL
GSE18520_top500tf - GSE18520 - SiGN-BN HC+BootstrapWhole-genome oligonucleotide expression analysis of papillary serous ovarian adenocarcinomas
GSE18521_top500tf - GSE18521 - SiGN-BN HC+BootstrapA gene signature predictive for outcome in advanced ovarian cancer identifies a novel survival factor: MAGP2
GSE18684_top500tf - GSE18684 - SiGN-BN HC+BootstrapFine mapping of androgen regulated genes in LNCaP cells
GSE18728_top500tf - GSE18728 - SiGN-BN HC+BootstrapExpression data from human breast cancers pre and post chemothrapy
GSE18842_top500tf - GSE18842 - SiGN-BN HC+BootstrapGene expression analysis of human lung cancer and control samples
GSE18864_top500tf - GSE18864 - SiGN-BN HC+BootstrapTumor expression data from neoadjuvant trial of cisplatin monotherapy in triple negative breast cancer patients
GSE19027_top500tf - GSE19027 - SiGN-BN HC+BootstrapAntioxidant response gene expression in the bronchial airway epithelial cells of smokers at risk for lung cancer
GSE19069_top500tf - GSE19069 - SiGN-BN HC+BootstrapMolecular signatures in peripheral T-cell lymphoma (PTCL)
GSE19188_top500tf - GSE19188 - SiGN-BN HC+BootstrapExpression data for early stage NSCLC
GSE19274_top500tf - GSE19274 - SiGN-BN HC+BootstrapExpression profiling in Neuroblastoma Primary tumors and Cell lines
GSE19417_top500tf - GSE19417 - SiGN-BN HC+BootstrapHuman esophageal adenocarcinomas
GSE19494_top500tf - GSE19494 - SiGN-BN HC+BootstrapSubcutaneous adipose tissue (SAT) gene expression patterns between weight control and regaining weight subjects
GSE19615_top500tf - GSE19615 - SiGN-BN HC+BootstrapIntegrated genomic and function characterization of the 8q22 gain
GSE19784_top500tf - GSE19784 - SiGN-BN HC+BootstrapGene expression profiling of multiple myeloma patients included in the HOVON65/GMMG-HD4 trial
GSE19804_top500tf - GSE19804 - SiGN-BN HC+BootstrapGenome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan
GSE20181_top500tf - GSE20181 - SiGN-BN HC+BootstrapLetrozole (Femara) early and late responses to treatment
GSE20189_top500tf - GSE20189 - SiGN-BN HC+BootstrapA gene expression signature from peripheral whole blood for stage I lung adenocarcinoma
GSE20194_top500tf - GSE20194 - SiGN-BN HC+BootstrapMAQC-II Project: human breast cancer (BR) data set
GSE20257_top500tf - GSE20257 - SiGN-BN HC+BootstrapSmoking-induced Disarray of the Apical Junctional Complex Gene Expression Architecture in the Human Airway Epithelium
GSE20271_top500tf - GSE20271 - SiGN-BN HC+BootstrapExpression data from breast cancer FNA biopsies from patients
GSE2034_top500tf - GSE2034 - SiGN-BN HC+BootstrapBreast cancer relapse free survival
GSE20685_top500tf - GSE20685 - SiGN-BN HC+BootstrapMicroarray-based molecular subtyping of breast cancer
GSE20842_top500tf - GSE20842 - SiGN-BN HC+BootstrapMutated KRAS induces overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas
GSE20916_top500tf - GSE20916 - SiGN-BN HC+BootstrapModeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data
GSE21029_top500tf - GSE21029 - SiGN-BN HC+BootstrapThe lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia (CLL)
GSE21050_top500tf - GSE21050 - SiGN-BN HC+BootstrapExpression data from Complex genetics sarcomas (cohort 1 and 2)
GSE21122_top500tf - GSE21122 - SiGN-BN HC+BootstrapWhole-transcript expression data for soft-tissue sarcoma tumors and control normal fat specimens
GSE2113_top500tf - GSE2113 - SiGN-BN HC+BootstrapPlasma cell dyscrasias expression profiles associated with distinct IGH translocations in multiple myeloma
GSE21452_top500tf - GSE21452 - SiGN-BN HC+BootstrapIntegrated genomic profiling in mantle cell lymphoma
GSE21501_top500tf - GSE21501 - SiGN-BN HC+BootstrapA six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma
GSE21510_top500tf - GSE21510 - SiGN-BN HC+BootstrapClinical Significance of Osteoprotegerin Expression in Human Colorectal Cancer
GSE21653_top500tf - GSE21653 - SiGN-BN HC+BootstrapA gene expression signature identifies two prognostic subgroups of basal breast cancer
GSE22093_top500tf - GSE22093 - SiGN-BN HC+BootstrapExpression data from breast cancer FNA biopsies from patients
GSE22138_top500tf - GSE22138 - SiGN-BN HC+BootstrapExpression Data from Uveal Melanoma primary tumors.
GSE22153_top500tf - GSE22153 - SiGN-BN HC+BootstrapGene Experssion Profiling-Based Identification of Molecular Subtypes in Stage IV Melanoma with Different Clinical Outcome (test set)
GSE22541_top500tf - GSE22541 - SiGN-BN HC+BootstrapExpression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals
GSE22597_top500tf - GSE22597 - SiGN-BN HC+BootstrapExpression data from Fine Needle Aspiration (FNA) biopsies from breast cancer patients
GSE2294_top500tf - GSE2294 - SiGN-BN HC+BootstrapA Modular Analysis of Breast Cancer Reveals a Novel Low-Grade Molecular Signature in Estrogen Receptor-Positive Tumors
GSE23036_top500tf - GSE23036 - SiGN-BN HC+BootstrapGene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma
GSE23120_top500tf - GSE23120 - SiGN-BN HC+BootstrapBasal gene expression data from Human Variation Panel
GSE23177_top500tf - GSE23177 - SiGN-BN HC+BootstrapPrediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs.
GSE23553_top500tf - GSE23553 - SiGN-BN HC+BootstrapGene expression changes with induction of in-vitro platinum-resistance in ovarian cancer cell lines.
GSE23593_top500tf - GSE23593 - SiGN-BN HC+BootstrapIntratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome
GSE23772_top500tf - GSE23772 - SiGN-BN HC+BootstrapWhy does HAMLET preferentially kill tumor cells? p38-dependent death in tumor but up-regulation of innate immunity in healthy, differentiated cells
GSE23806_top500tf - GSE23806 - SiGN-BN HC+BootstrapExpression data of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors
GSE23878_top500tf - GSE23878 - SiGN-BN HC+BootstrapGenome Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy
GSE23980_top500tf - GSE23980 - SiGN-BN HC+BootstrapExpression data from human soft tissue sarcomas with complex genomics
GSE23988_top500tf - GSE23988 - SiGN-BN HC+BootstrapExpression data from breast cancer FNA biopsies from patients (US samples)
GSE23991_top500tf - GSE23991 - SiGN-BN HC+BootstrapEffect of zebularine on primary human liver cancer cell lines
GSE24080_top500tf - GSE24080 - SiGN-BN HC+BootstrapMAQC-II Project: Multiple myeloma (MM) data set
GSE24124_top500tf - GSE24124 - SiGN-BN HC+BootstrapMajor gene partners of a favorable biomarker in ER(+) breast cancer
GSE24185_top500tf - GSE24185 - SiGN-BN HC+BootstrapGene transcription signature of obesity in breast cancer
GSE25055_top500tf - GSE25055 - SiGN-BN HC+BootstrapDiscovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer
GSE25065_top500tf - GSE25065 - SiGN-BN HC+BootstrapValidation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer
GSE25066_top500tf - GSE25066 - SiGN-BN HC+BootstrapGenomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer
GSE25136_top500tf - GSE25136 - SiGN-BN HC+BootstrapOptimizing molecular signatures for prostate cancer recurrence
GSE25428_top500tf - GSE25428 - SiGN-BN HC+BootstrapGene expression profiles of ovarian cancer cell lines in the presence and absence of a DNA methyltransferase inhibitor
GSE2549_top500tf - GSE2549 - SiGN-BN HC+BootstrapMalignant pleural mesothelioma
GSE2603_top500tf - GSE2603 - SiGN-BN HC+BootstrapSubpopulations of MDA-MB-231 and Primary Breast Cancers
GSE26549_top500tf - GSE26549 - SiGN-BN HC+BootstrapGene Expression Profiling Predicts the Development of Oral Cancer
GSE26599_top500tf - GSE26599 - SiGN-BN HC+BootstrapGene expression profile in response to doxorubicin-rapamycin combined treatment of HER-2 overexpressing human mammary epithelial cell lines
GSE26639_top500tf - GSE26639 - SiGN-BN HC+BootstrapExpression Data from 226 patients of the REMAGUS02 trial
GSE26712_top500tf - GSE26712 - SiGN-BN HC+BootstrapA Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer
GSE26906_top500tf - GSE26906 - SiGN-BN HC+BootstrapAPC colon stage II
GSE27155_top500tf - GSE27155 - SiGN-BN HC+BootstrapHuman thyroid adenomas, carcinomas, and normals
GSE27480_top500tf - GSE27480 - SiGN-BN HC+BootstrapGene-expression analysis of Oncostatin-M (OSM) signalling in cervical squamous cell carcinomas over-expressing the Oncostatin-M receptor (OSMR)
GSE27562_top500tf - GSE27562 - SiGN-BN HC+BootstrapExpression data from human PBMCs from breast cancer patients and controls
GSE2841_top500tf - GSE2841 - SiGN-BN HC+BootstrapExpression Profiling of pheochromocytomas of various genetic origins
GSE28497_top500tf - GSE28497 - SiGN-BN HC+BootstrapNew markers for minimal residual disease detection in acute lymphoblastic leukemia
GSE28821_top500tf - GSE28821 - SiGN-BN HC+BootstrapLaser-capture microdissected invasive micropapillary carcinomas of the breast
GSE29013_top500tf - GSE29013 - SiGN-BN HC+BootstrapRobust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non-Small-Cell Lung Cancer Patients
GSE2912_top500tf - GSE2912 - SiGN-BN HC+BootstrapMolecular classification of multiple myeloma
GSE29288_top500tf - GSE29288 - SiGN-BN HC+BootstrapComparison between cell lines from 9 different cancer tissue (NCI-60) (Agilent WG platform)
GSE29354_top500tf - GSE29354 - SiGN-BN HC+BootstrapMesothelioma tumor gene expression profiles
GSE29598_top500tf - GSE29598 - SiGN-BN HC+BootstrapA Methodology for Utilization of Predictive Genomic Signatures in FFPE Samples
GSE29683_top500tf - GSE29683 - SiGN-BN HC+BootstrapCoexpression of Normally Incompatible Developmental Pathways in Retinoblastoma Genesis [human tumor/cell line data]
GSE29817_top500tf - GSE29817 - SiGN-BN HC+BootstrapMembranous Expression of Ectodomain Isoforms of the Epidermal Growth Factor Receptor (EGFR) Predicts Outcome after Chemoradiotherapy of Lymph Node Negative Cervical Cancer
GSE2990_top500tf - GSE2990 - SiGN-BN HC+BootstrapGene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
GSE30240_top500tf - GSE30240 - SiGN-BN HC+BootstrapExpression data from 5 human cell lines exposed to IR (5 Gy)
GSE30375_top500tf - GSE30375 - SiGN-BN HC+BootstrapGene expression data from sorted and unsorted primary human acute myeloid leukemia (AML) samples
GSE30784_top500tf - GSE30784 - SiGN-BN HC+BootstrapGene expression profiling of oral squamous cell carcinoma (OSCC)
GSE30929_top500tf - GSE30929 - SiGN-BN HC+BootstrapWhole-transcript expression data for liposarcoma
GSE31245_top500tf - GSE31245 - SiGN-BN HC+BootstrapUnique gene expression profile based upon pathologic response in epithelial ovarian cancer
GSE31279_top500tf - GSE31279 - SiGN-BN HC+BootstrapDecoding differentially regulated epithelial and stromal pathways in colorectal cancer
GSE3141_top500tf - GSE3141 - SiGN-BN HC+BootstrapLung Cancer Dataset
GSE3143_top500tf - GSE3143 - SiGN-BN HC+BootstrapBreast Cancer Dataset
GSE3149_top500tf - GSE3149 - SiGN-BN HC+BootstrapOvarian Cancer Dataset
GSE3151_top500tf - GSE3151 - SiGN-BN HC+BootstrapOncogene Signature Dataset
GSE31519_top500tf - GSE31519 - SiGN-BN HC+BootstrapA Clinically Relevant Gene Signature in Triple-Negative and Basal-Like Breast Cancer
GSE31547_top500tf - GSE31547 - SiGN-BN HC+BootstrapMSKCC-A Primary Lung Cancer Specimens
GSE31548_top500tf - GSE31548 - SiGN-BN HC+BootstrapMSKCC-B Primary Lung Cancer Specimens
GSE31552_top500tf - GSE31552 - SiGN-BN HC+BootstrapExpression Data from human Lung tissue of Patients with Non Small Cell Lung Cancer (NSCLC)
GSE3167_top500tf - GSE3167 - SiGN-BN HC+BootstrapClassification of carcinoma in situ lesions in human bladder cancer
GSE32269_top500tf - GSE32269 - SiGN-BN HC+BootstrapExpression data for primary localized prostate cancer versus castration-resistant bone metastatic prostate cancer
GSE32448_top500tf - GSE32448 - SiGN-BN HC+BootstrapCPDR tumor-benign 80 genechip dataset
GSE32474_top500tf - GSE32474 - SiGN-BN HC+BootstrapComparison between cell lines from 9 different cancer tissue (NCI-60) (Affymetrix U133 Plus 2.0)
GSE3593_top500tf - GSE3593 - SiGN-BN HC+BootstrapGenomic approach to refine prognosis for adjuvant therapy in early stage non-small cell lung carcinoma
GSE3629_top500tf - GSE3629 - SiGN-BN HC+BootstrapMolecular Marker for predicting development of cancer in ulcerative colitis
GSE3726_top500tf - GSE3726 - SiGN-BN HC+BootstrapPrognostic gene signatures can be measured with samples stored in RNAlater
GSE3960_top500tf - GSE3960 - SiGN-BN HC+BootstrapClassification of neuroblastoma by integrating gene expression pattern with regional alterations in DNA copy number
GSE4115_top500tf - GSE4115 - SiGN-BN HC+BootstrapAirway Epithelial Gene Expression Diagnostic for the Evaluation of Smokers with Suspect Lung Cancer
GSE4122_top500tf - GSE4122 - SiGN-BN HC+BootstrapGene Expression Analysis of Ovarian Samples
GSE4183_top500tf - GSE4183 - SiGN-BN HC+BootstrapInflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature
GSE4290_top500tf - GSE4290 - SiGN-BN HC+BootstrapExpression data of glioma samples from Henry Ford Hospital
GSE4452_top500tf - GSE4452 - SiGN-BN HC+BootstrapGene Expression Profiles of Multiple Myeloma (N=65) Before Treatment
GSE4459_top500tf - GSE4459 - SiGN-BN HC+BootstrapGene expression signature and the prediction of lymph node metastases
GSE4536_top500tf - GSE4536 - SiGN-BN HC+BootstrapTumor stem cells more closely mirror the phenotype and genotype of primary human tumors than do cancer cell lines
GSE4554_top500tf - GSE4554 - SiGN-BN HC+BootstrapGene expression signature of colorectal cancer with microsatellite instability.
GSE4573_top500tf - GSE4573 - SiGN-BN HC+BootstrapGene expression signatures for predicting prognosis of squamous cell lung carcinomas
GSE4581_top500tf - GSE4581 - SiGN-BN HC+BootstrapGene Expression Profiles of Multiple Myeloma (N=414) Before Treatment
GSE4823_top500tf - GSE4823 - SiGN-BN HC+BootstrapComparison of normal breast epithelium and stroma from reduction and I.D.C. cases
GSE5107_top500tf - GSE5107 - SiGN-BN HC+BootstrapDistinct Transcription Profiles of Primary and Secondary Glioblastomas
GSE5206_top500tf - GSE5206 - SiGN-BN HC+BootstrapLarge-scale deployment of embryonic gene programming in human and murine colon cancer: a new target for intervention.
GSE5327_top500tf - GSE5327 - SiGN-BN HC+BootstrapBreast cancer relapse free survival and lung metastasis free survival
GSE5364_top500tf - GSE5364 - SiGN-BN HC+BootstrapA Precisely Regulated Gene Expression Cassette Potently Modulates Metastasis and Survival in Multiple Solid Cancers
GSE5460_top500tf - GSE5460 - SiGN-BN HC+BootstrapPredicting Features of Breast Cancer with Gene Expression Patterns
GSE5462_top500tf - GSE5462 - SiGN-BN HC+BootstrapLetrozole (Femara) early response to treatment
GSE5846_top500tf - GSE5846 - SiGN-BN HC+BootstrapNCI-60 Cancer Cell Line
GSE5847_top500tf - GSE5847 - SiGN-BN HC+BootstrapTumor and stroma from breast by LCM
GSE5851_top500tf - GSE5851 - SiGN-BN HC+BootstrapPhase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC
GSE5900_top500tf - GSE5900 - SiGN-BN HC+BootstrapGene Expression of Bone Marrow Plasma Cells from Healthy Donors (N=22), MGUS (N=44), and Smoldering Myeloma (N=12)
GSE6008_top500tf - GSE6008 - SiGN-BN HC+BootstrapHuman ovarian tumors and normal ovaries
GSE6338_top500tf - GSE6338 - SiGN-BN HC+BootstrapGene expression analysis of Peripheral T-cell Lymphoma/Unspecified
GSE6365_top500tf - GSE6365 - SiGN-BN HC+BootstrapDistinct transcriptional and genetic features associated with chromosome 13 deletion in multiple myeloma
GSE6401_top500tf - GSE6401 - SiGN-BN HC+BootstrapUp-regulation of translational machinery and distinct genetic subgroups characterize hyperdiploidy in multiple myeloma
GSE6462_top500tf - GSE6462 - SiGN-BN HC+BootstrapMCF7 dose response
GSE6465_top500tf - GSE6465 - SiGN-BN HC+BootstrapExpression data of Hepatocellular Carcinoma
GSE6477_top500tf - GSE6477 - SiGN-BN HC+BootstrapExpression data from different stages of plasma cell neoplasm
GSE6481_top500tf - GSE6481 - SiGN-BN HC+BootstrapGene Expression Analysis of Soft Tissue Sarcomas: Characterization & Reclassification of Malignant Fibrous Histiocytoma
GSE6691_top500tf - GSE6691 - SiGN-BN HC+BootstrapGene expression profiling of B lymphocytes and plasma cells from WaldenstrÖm’s macroglobulinemia.
GSE6764_top500tf - GSE6764 - SiGN-BN HC+BootstrapGenome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma
GSE6791_top500tf - GSE6791 - SiGN-BN HC+BootstrapGene Expression Profiles of HPV-Positive and -Negative Head/Neck and Cervical Cancers
GSE6956_top500tf - GSE6956 - SiGN-BN HC+BootstrapTumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men
GSE7208_top500tf - GSE7208 - SiGN-BN HC+BootstrapExpression data from 59 human colon tumor tissue samples
GSE7390_top500tf - GSE7390 - SiGN-BN HC+BootstrapStrong Time Dependence of the 76-Gene Prognostic Signature
GSE7553_top500tf - GSE7553 - SiGN-BN HC+BootstrapGene Expression Patterns Involved in the Malignant Transformation and Progression of Metastatic Melanoma
GSE7604_top500tf - GSE7604 - SiGN-BN HC+BootstrapHuman Colon tumor vs Normal Human DNA
GSE7606_top500tf - GSE7606 - SiGN-BN HC+BootstrapHuman Melanoma vs Normal Human DNA
GSE7670_top500tf - GSE7670 - SiGN-BN HC+BootstrapExpression data from Lung cancer
GSE7696_top500tf - GSE7696 - SiGN-BN HC+BootstrapGlioblastoma from a homogenous cohort of patients treated within clinical trial
GSE7849_top500tf - GSE7849 - SiGN-BN HC+BootstrapAge-Specific Differences of Oncogenic Pathway Deregulation Seen in Human Breast Tumors
GSE7904_top500tf - GSE7904 - SiGN-BN HC+BootstrapExpression data from human breast tissue
GSE8057_top500tf - GSE8057 - SiGN-BN HC+BootstrapExpression data from ovarian cancer cells with time-course and concentration-profiles
GSE8141_top500tf - GSE8141 - SiGN-BN HC+BootstrapExpression data from MCF7 wt and MCF7/HER2-18 xenografts
GSE8332_top500tf - GSE8332 - SiGN-BN HC+BootstrapDeath receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL
GSE8401_top500tf - GSE8401 - SiGN-BN HC+BootstrapGene Signature for Aggression of Melanoma Metastases - Melanoma Metastasis
GSE8481_top500tf - GSE8481 - SiGN-BN HC+BootstrapVarious human cell types
GSE8546_top500tf - GSE8546 - SiGN-BN HC+BootstrapGene Expression Changes in Myeloma Cells Following Short Term In-vivo Drug Exposure
GSE8581_top500tf - GSE8581 - SiGN-BN HC+BootstrapHuman Chronic Obstructive Pulmonary Disorder (COPD) Biomarker
GSE8671_top500tf - GSE8671 - SiGN-BN HC+BootstrapTranscriptome profile of human colorectal adenomas.
GSE8835_top500tf - GSE8835 - SiGN-BN HC+BootstrapChronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells.
GSE8894_top500tf - GSE8894 - SiGN-BN HC+BootstrapPrediction of Recurrence-Free Survival in Postoperative NSCLC Patients—a Useful Prospective Clinical Practice
GSE9169_top500tf - GSE9169 - SiGN-BN HC+BootstrapGene expression during neuronal differentiation in two subtypes of SH-SY5Y
GSE9348_top500tf - GSE9348 - SiGN-BN HC+BootstrapExpression data from healthy controls and early stage CRC patient's tumor
GSE9992_top500tf - GSE9992 - SiGN-BN HC+BootstrapMolecular and transcriptional characterization of chromosome 17p loss in chronic lymphocytic leukemia, experiment A
GSE8139_top500tf - GSE8139 - SiGN-BN HC+BootstrapExpression data from MCF7/HER2-18 xenografts
GSE8218_top500tf - GSE8218 - SiGN-BN HC+BootstrapGene expression data from prostate cancer samples
GSE9014_top500tf - GSE9014 - SiGN-BN HC+BootstrapTumor-associated stroma derived from primary clinical breast cancer samples
GSE9195_top500tf - GSE9195 - SiGN-BN HC+BootstrapPredicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
GSE9309_top500tf - GSE9309 - SiGN-BN HC+BootstrapRecovery of biological information under heterogeneous experimental conditions using subgroup standardization.
GSE9750_top500tf - GSE9750 - SiGN-BN HC+BootstrapIdentification of gene expression profiles in cervical cancer
GSE9843_top500tf - GSE9843 - SiGN-BN HC+BootstrapGene expression profiling of 91 hepatocellular carcinomas with hepatitis C virus etiology
GSE9936_top500tf - GSE9936 - SiGN-BN HC+BootstrapExpression data from human breast cancer cells (MCF-7) coexpressing ERalpha and Erbeta, treated with phytoestrogens
GSE10063_egf1520 - GSE10063 - SiGN-BN HC+BootstrapEffects of tobacco smoke on gene expression and cellular pathways in a cellular model of oral leukoplakia
GSE10072_egf1520 - GSE10072 - SiGN-BN HC+BootstrapGene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival
GSE10138_egf1520 - GSE10138 - SiGN-BN HC+BootstrapA Genomic Approach to Improve Prognosis and Predict Therapeutic Response in Chronic Lymphocytic Leukemia (Duke_VA)
GSE10245_egf1520 - GSE10245 - SiGN-BN HC+BootstrapGene expression differences between adenocarcinoma and squamous cell carcinoma in human NSCLC
GSE10320_egf1520 - GSE10320 - SiGN-BN HC+BootstrapPredicting Relapse in Favorable Histology Wilms Tumor Using Gene Expression
GSE10327_egf1520 - GSE10327 - SiGN-BN HC+BootstrapmRNA expression data of 62 human medulloblastoma tumors
GSE10358_egf1520 - GSE10358 - SiGN-BN HC+BootstrapDiscovery and validation of expression data for the Genomics of Acute Myeloid Leukemia Program at Washington University.
GSE10445_egf1520 - GSE10445 - SiGN-BN HC+BootstrapMERLION LUNG CANCER STUDY
GSE10780_egf1520 - GSE10780 - SiGN-BN HC+BootstrapProliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue
GSE10797_egf1520 - GSE10797 - SiGN-BN HC+BootstrapTranscriptomes of breast epithelium and stroma in normal reduction mammoplasty and invasive breast cancer patients.
GSE10810_egf1520 - GSE10810 - SiGN-BN HC+BootstrapGene expression signatures in breast cancer distinguish phenotype charact., histological subtypes, and tumor invasivness
GSE10843_egf1520 - GSE10843 - SiGN-BN HC+BootstrapmRNA Cancer Cell Line Profiles
GSE10890_egf1520 - GSE10890 - SiGN-BN HC+BootstrapmRNA Breast Cancer Cell Line Profiles
GSE10927_egf1520 - GSE10927 - SiGN-BN HC+BootstrapHuman adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10), on Affymetrix HG_U133_plus_2 arrays
GSE10972_egf1520 - GSE10972 - SiGN-BN HC+BootstrapColon cancer
GSE11121_egf1520 - GSE11121 - SiGN-BN HC+BootstrapThe humoral immune system has a key prognostic impact in node-negative breast cancer
GSE11135_egf1520 - GSE11135 - SiGN-BN HC+BootstrapThe MILE (Microarray Innovations In LEukemia) study pre-phase
GSE11151_egf1520 - GSE11151 - SiGN-BN HC+BootstrapGene expression data from different types of renal tumors and normal kidneys
GSE11482_egf1520 - GSE11482 - SiGN-BN HC+BootstrapRhabdoid Tumor: Gene Expression Clues to Pathogenesis and Potential Therapeutic Targets
GSE11582_egf1520 - GSE11582 - SiGN-BN HC+BootstrapGenetic Analysis of Human Traits In-Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines
GSE11729_egf1520 - GSE11729 - SiGN-BN HC+BootstrapH1299 EGF and Iressa stimulation
GSE11869_egf1520 - GSE11869 - SiGN-BN HC+BootstrapThe genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol.
GSE12093_egf1520 - GSE12093 - SiGN-BN HC+BootstrapThe 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy
GSE12195_egf1520 - GSE12195 - SiGN-BN HC+BootstrapMutations of multiple genes deregulate the NF-kB pathway in diffuse large B cell lymphoma
GSE12276_egf1520 - GSE12276 - SiGN-BN HC+BootstrapExpression data from primary breast tumors
GSE12391_egf1520 - GSE12391 - SiGN-BN HC+BootstrapMelanoma: comparison between common nevi, radial/vertical growth phase melanoma, metastases and dysplastic nevi
GSE12428_egf1520 - GSE12428 - SiGN-BN HC+BootstrapCurrent smoking-specific gene expression signature in bronchial epithelium is enhanced in squamous cell lung cancer
GSE12453_egf1520 - GSE12453 - SiGN-BN HC+BootstrapOrigin and pathogenesis of lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis
GSE12460_egf1520 - GSE12460 - SiGN-BN HC+BootstrapExpression profiling of neuroblastic tumors
GSE12470_egf1520 - GSE12470 - SiGN-BN HC+BootstrapGene expression profiles of serous ovarian cancer samples
GSE12472_egf1520 - GSE12472 - SiGN-BN HC+BootstrapA COPD-related gene expression signature in squamous cell lung cancer
GSE12622_egf1520 - GSE12622 - SiGN-BN HC+BootstrapTumor-associated stroma derived from primary clinical breast cancer samples (II)
GSE12627_egf1520 - GSE12627 - SiGN-BN HC+BootstrapNon-supervised hierarchical clustering of gene expression data
GSE12667_egf1520 - GSE12667 - SiGN-BN HC+BootstrapDiscovery of somatic mutations in lung adenocarcinomas
GSE12682_egf1520 - GSE12682 - SiGN-BN HC+BootstrapExpression data from Human Kidney (HK) samples
GSE12777_egf1520 - GSE12777 - SiGN-BN HC+BootstrapGene expression profiling of 51 human breast cancer cell lines
GSE12790_egf1520 - GSE12790 - SiGN-BN HC+BootstrapGene expression profiling of human breast cancers and cancer cell lines
GSE12945_egf1520 - GSE12945 - SiGN-BN HC+BootstrapExpression data from colorectal cancers
GSE13009_egf1520 - GSE13009 - SiGN-BN HC+BootstrapMCF7 EGF, HRG stimulation
GSE13067_egf1520 - GSE13067 - SiGN-BN HC+BootstrapExpression data from primary colorectal cancers
GSE13168_egf1520 - GSE13168 - SiGN-BN HC+BootstrapEffects of glucocorticoids and Protein Kinase A on growth factor- and 1beta- regulated gene
GSE13255_egf1520 - GSE13255 - SiGN-BN HC+BootstrapGene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients with NonSmall Cell Lung Cancer.
GSE13294_egf1520 - GSE13294 - SiGN-BN HC+BootstrapExpression data from primary colorectal cancers
GSE13507_egf1520 - GSE13507 - SiGN-BN HC+BootstrapPredective Value of Prognosis-Related Gene Expression Study in Primary Bladder Cancer
GSE13591_egf1520 - GSE13591 - SiGN-BN HC+BootstrapIntegrated genomics approach to detect allelic imbalances in multiple myeloma
GSE13598_egf1520 - GSE13598 - SiGN-BN HC+BootstrapmRNA expression of 131 cancer cell lines
GSE13601_egf1520 - GSE13601 - SiGN-BN HC+BootstrapOral tongue cancer gene expression profiling: Identification of novel potential prognosticators
GSE13861_egf1520 - GSE13861 - SiGN-BN HC+BootstrapGene expression signature-based novel prognostic risk score in gastric cancer
GSE13898_egf1520 - GSE13898 - SiGN-BN HC+BootstrapRobust prognostic biomarkers for EAC identified by systems-level characterization of tumor transcriptome
GSE13911_egf1520 - GSE13911 - SiGN-BN HC+BootstrapExpression data from primary gastric tumors (MSI and MSS) and adjacent normal samples
GSE13996_egf1520 - GSE13996 - SiGN-BN HC+BootstrapMolecular profiling of classical Hodgkin’s lymphoma tissues
GSE14095_egf1520 - GSE14095 - SiGN-BN HC+BootstrapGene expression signature and the prediction of liver metastasis in colorectal cancer by DNA microarray
GSE14206_egf1520 - GSE14206 - SiGN-BN HC+BootstrapAnalysis of ETS gene expression patterns uncovers novel ETS mediated gene silencing pathways in prostate cancers
GSE14208_egf1520 - GSE14208 - SiGN-BN HC+BootstrapClinical response of metastatic gastric cancer patients to cisplatin and fluorouracil (CF) combination chemotherapy
GSE14210_egf1520 - GSE14210 - SiGN-BN HC+BootstrapExpression data from human endoscopic biopsy samples
GSE14315_egf1520 - GSE14315 - SiGN-BN HC+BootstrapEffects of demethylation on lung cancer cell lines
GSE14333_egf1520 - GSE14333 - SiGN-BN HC+BootstrapExpression data from 290 primary colorectal cancers
GSE14764_egf1520 - GSE14764 - SiGN-BN HC+BootstrapA Prognostic Gene Expression Index in Ovarian Cancer
GSE14786_egf1520 - GSE14786 - SiGN-BN HC+BootstrapGene expression analysis of cancer-related fatigue in whole blood from breast cancer survivors
GSE14814_egf1520 - GSE14814 - SiGN-BN HC+BootstrapPrognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer
GSE14879_egf1520 - GSE14879 - SiGN-BN HC+BootstrapGene expression study of anaplastic large cell lymphomas: cellular origin, pathogenesis and relation to Hodgkin lymphoma
GSE14925_egf1520 - GSE14925 - SiGN-BN HC+BootstrapExpression data from Non small cell lung cancer cell lines
GSE15212_egf1520 - GSE15212 - SiGN-BN HC+BootstrapIdentification and validation of NOL5A and RPS2 as potential therapeutic targtes in colorectal cancer
GSE15329_egf1520 - GSE15329 - SiGN-BN HC+BootstrapGene expression profiling of human non-Hodgkins lymphoma (NHL) cell lines
GSE15395_egf1520 - GSE15395 - SiGN-BN HC+BootstrapHCT116 tumor cells treated with a CDK inhibitor
GSE15396_egf1520 - GSE15396 - SiGN-BN HC+BootstrapPeripheral blood mononuclear, DU145, and HCT116 cells treated with a CDK inhibitor
GSE15459_egf1520 - GSE15459 - SiGN-BN HC+BootstrapGastric Cancer Project '08 (Singapore Patient Cohort)
GSE15471_egf1520 - GSE15471 - SiGN-BN HC+BootstrapWhole-Tissue Gene Expression Study of Pancreatic Ductal Adenocarcinoma
GSE15641_egf1520 - GSE15641 - SiGN-BN HC+BootstrapGene signatures of progression and metastasis in renal cell cancer
GSE15765_egf1520 - GSE15765 - SiGN-BN HC+BootstrapIdentification of cholangiocarcinoma-like gene expression traits in hepatocellular carcinoma
GSE15852_egf1520 - GSE15852 - SiGN-BN HC+BootstrapExpression data from human breast tumors and their paired normal tissues
GSE15966_egf1520 - GSE15966 - SiGN-BN HC+BootstrapGene expression signature predictive of rapid response to imatinib mesylate in Gastrointestinal Stromal Tumor (GIST)
GSE16120_egf1520 - GSE16120 - SiGN-BN HC+BootstrapGene profiling, mutations and expression of epidermal growth factor receptor in androgen-dependent prostate cancer
GSE16237_egf1520 - GSE16237 - SiGN-BN HC+BootstrapExpression data of human neuroblastoma tissue samples
GSE16382_egf1520 - GSE16382 - SiGN-BN HC+BootstrapExpression data from complex genetic sarcomas
GSE16391_egf1520 - GSE16391 - SiGN-BN HC+BootstrapGGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial
GSE16446_egf1520 - GSE16446 - SiGN-BN HC+BootstrapPredicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial
GSE16455_egf1520 - GSE16455 - SiGN-BN HC+BootstrapIndolent MCL identified by genomic and gene expression profiling
GSE16515_egf1520 - GSE16515 - SiGN-BN HC+BootstrapExpression data from Mayo Clinic Pancreatic Tumor and Normal samples
GSE16581_egf1520 - GSE16581 - SiGN-BN HC+BootstrapGenomic landscape of meningiomas: gene expression
GSE16757_egf1520 - GSE16757 - SiGN-BN HC+BootstrapGene expression study in hepatocellular carcinoma
GSE16987_egf1520 - GSE16987 - SiGN-BN HC+BootstrapA new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis
GSE17372_egf1520 - GSE17372 - SiGN-BN HC+BootstrapMolecular Classification of AIDS-Related Lymphomas [including third-party data]
GSE17536_egf1520 - GSE17536 - SiGN-BN HC+BootstrapMetastasis Gene Expression Profile Predicts Recurrence and Death in Colon Cancer Patients (Moffitt Samples)
GSE17537_egf1520 - GSE17537 - SiGN-BN HC+BootstrapMetastasis Gene Expression Profile Predicts Recurrence and Death in Colon Cancer Patients (VMC Samples)
GSE17705_egf1520 - GSE17705 - SiGN-BN HC+BootstrapEndocrine Sensitivity Index Validation Dataset
GSE17764_egf1520 - GSE17764 - SiGN-BN HC+BootstrapExpression profiles associated with BRCA1 and BRCA2 mutation status in familial breast cancer patients
GSE17913_egf1520 - GSE17913 - SiGN-BN HC+BootstrapEffects of Cigarette Smoke on the Human Oral Mucosal Transcriptome
GSE17920_egf1520 - GSE17920 - SiGN-BN HC+BootstrapExpression data of diagnostic biopsy samples from Hodgkin lymphoma patients
GSE17951_egf1520 - GSE17951 - SiGN-BN HC+BootstrapGene expression analysis of prostate cancer samples using Affymetrix U133Plus2 array
GSE18088_egf1520 - GSE18088 - SiGN-BN HC+BootstrapCorrelation of molecular profiles and clinical outcome of stage UICC II colon cancer patients
GSE18105_egf1520 - GSE18105 - SiGN-BN HC+BootstrapStage II and stage III colorectal cancer
GSE18497_egf1520 - GSE18497 - SiGN-BN HC+BootstrapDiagnosis-relapse in ALL
GSE18520_egf1520 - GSE18520 - SiGN-BN HC+BootstrapWhole-genome oligonucleotide expression analysis of papillary serous ovarian adenocarcinomas
GSE18521_egf1520 - GSE18521 - SiGN-BN HC+BootstrapA gene signature predictive for outcome in advanced ovarian cancer identifies a novel survival factor: MAGP2
GSE18684_egf1520 - GSE18684 - SiGN-BN HC+BootstrapFine mapping of androgen regulated genes in LNCaP cells
GSE18728_egf1520 - GSE18728 - SiGN-BN HC+BootstrapExpression data from human breast cancers pre and post chemothrapy
GSE18842_egf1520 - GSE18842 - SiGN-BN HC+BootstrapGene expression analysis of human lung cancer and control samples
GSE18864_egf1520 - GSE18864 - SiGN-BN HC+BootstrapTumor expression data from neoadjuvant trial of cisplatin monotherapy in triple negative breast cancer patients
GSE19027_egf1520 - GSE19027 - SiGN-BN HC+BootstrapAntioxidant response gene expression in the bronchial airway epithelial cells of smokers at risk for lung cancer
GSE19069_egf1520 - GSE19069 - SiGN-BN HC+BootstrapMolecular signatures in peripheral T-cell lymphoma (PTCL)
GSE19188_egf1520 - GSE19188 - SiGN-BN HC+BootstrapExpression data for early stage NSCLC
GSE19274_egf1520 - GSE19274 - SiGN-BN HC+BootstrapExpression profiling in Neuroblastoma Primary tumors and Cell lines
GSE19417_egf1520 - GSE19417 - SiGN-BN HC+BootstrapHuman esophageal adenocarcinomas
GSE19494_egf1520 - GSE19494 - SiGN-BN HC+BootstrapSubcutaneous adipose tissue (SAT) gene expression patterns between weight control and regaining weight subjects
GSE19615_egf1520 - GSE19615 - SiGN-BN HC+BootstrapIntegrated genomic and function characterization of the 8q22 gain
GSE19784_egf1520 - GSE19784 - SiGN-BN HC+BootstrapGene expression profiling of multiple myeloma patients included in the HOVON65/GMMG-HD4 trial
GSE19804_egf1520 - GSE19804 - SiGN-BN HC+BootstrapGenome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan
GSE20181_egf1520 - GSE20181 - SiGN-BN HC+BootstrapLetrozole (Femara) early and late responses to treatment
GSE20189_egf1520 - GSE20189 - SiGN-BN HC+BootstrapA gene expression signature from peripheral whole blood for stage I lung adenocarcinoma
GSE20194_egf1520 - GSE20194 - SiGN-BN HC+BootstrapMAQC-II Project: human breast cancer (BR) data set
GSE20257_egf1520 - GSE20257 - SiGN-BN HC+BootstrapSmoking-induced Disarray of the Apical Junctional Complex Gene Expression Architecture in the Human Airway Epithelium
GSE20271_egf1520 - GSE20271 - SiGN-BN HC+BootstrapExpression data from breast cancer FNA biopsies from patients
GSE2034_egf1520 - GSE2034 - SiGN-BN HC+BootstrapBreast cancer relapse free survival
GSE20685_egf1520 - GSE20685 - SiGN-BN HC+BootstrapMicroarray-based molecular subtyping of breast cancer
GSE20842_egf1520 - GSE20842 - SiGN-BN HC+BootstrapMutated KRAS induces overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas
GSE20916_egf1520 - GSE20916 - SiGN-BN HC+BootstrapModeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data
GSE21029_egf1520 - GSE21029 - SiGN-BN HC+BootstrapThe lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia (CLL)
GSE21050_egf1520 - GSE21050 - SiGN-BN HC+BootstrapExpression data from Complex genetics sarcomas (cohort 1 and 2)
GSE21122_egf1520 - GSE21122 - SiGN-BN HC+BootstrapWhole-transcript expression data for soft-tissue sarcoma tumors and control normal fat specimens
GSE2113_egf1520 - GSE2113 - SiGN-BN HC+BootstrapPlasma cell dyscrasias expression profiles associated with distinct IGH translocations in multiple myeloma
GSE21452_egf1520 - GSE21452 - SiGN-BN HC+BootstrapIntegrated genomic profiling in mantle cell lymphoma
GSE21501_egf1520 - GSE21501 - SiGN-BN HC+BootstrapA six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma
GSE21510_egf1520 - GSE21510 - SiGN-BN HC+BootstrapClinical Significance of Osteoprotegerin Expression in Human Colorectal Cancer
GSE21653_egf1520 - GSE21653 - SiGN-BN HC+BootstrapA gene expression signature identifies two prognostic subgroups of basal breast cancer
GSE22093_egf1520 - GSE22093 - SiGN-BN HC+BootstrapExpression data from breast cancer FNA biopsies from patients
GSE22138_egf1520 - GSE22138 - SiGN-BN HC+BootstrapExpression Data from Uveal Melanoma primary tumors.
GSE22153_egf1520 - GSE22153 - SiGN-BN HC+BootstrapGene Experssion Profiling-Based Identification of Molecular Subtypes in Stage IV Melanoma with Different Clinical Outcome (test set)
GSE22541_egf1520 - GSE22541 - SiGN-BN HC+BootstrapExpression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals
GSE22597_egf1520 - GSE22597 - SiGN-BN HC+BootstrapExpression data from Fine Needle Aspiration (FNA) biopsies from breast cancer patients
GSE2294_egf1520 - GSE2294 - SiGN-BN HC+BootstrapA Modular Analysis of Breast Cancer Reveals a Novel Low-Grade Molecular Signature in Estrogen Receptor-Positive Tumors
GSE23036_egf1520 - GSE23036 - SiGN-BN HC+BootstrapGene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma
GSE23120_egf1520 - GSE23120 - SiGN-BN HC+BootstrapBasal gene expression data from Human Variation Panel
GSE23177_egf1520 - GSE23177 - SiGN-BN HC+BootstrapPrediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs.
GSE23553_egf1520 - GSE23553 - SiGN-BN HC+BootstrapGene expression changes with induction of in-vitro platinum-resistance in ovarian cancer cell lines.
GSE23593_egf1520 - GSE23593 - SiGN-BN HC+BootstrapIntratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome
GSE23772_egf1520 - GSE23772 - SiGN-BN HC+BootstrapWhy does HAMLET preferentially kill tumor cells? p38-dependent death in tumor but up-regulation of innate immunity in healthy, differentiated cells
GSE23806_egf1520 - GSE23806 - SiGN-BN HC+BootstrapExpression data of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors
GSE23878_egf1520 - GSE23878 - SiGN-BN HC+BootstrapGenome Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy
GSE23980_egf1520 - GSE23980 - SiGN-BN HC+BootstrapExpression data from human soft tissue sarcomas with complex genomics
GSE23988_egf1520 - GSE23988 - SiGN-BN HC+BootstrapExpression data from breast cancer FNA biopsies from patients (US samples)
GSE23991_egf1520 - GSE23991 - SiGN-BN HC+BootstrapEffect of zebularine on primary human liver cancer cell lines
GSE24080_egf1520 - GSE24080 - SiGN-BN HC+BootstrapMAQC-II Project: Multiple myeloma (MM) data set
GSE24124_egf1520 - GSE24124 - SiGN-BN HC+BootstrapMajor gene partners of a favorable biomarker in ER(+) breast cancer
GSE24185_egf1520 - GSE24185 - SiGN-BN HC+BootstrapGene transcription signature of obesity in breast cancer
GSE25055_egf1520 - GSE25055 - SiGN-BN HC+BootstrapDiscovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer
GSE25065_egf1520 - GSE25065 - SiGN-BN HC+BootstrapValidation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer
GSE25066_egf1520 - GSE25066 - SiGN-BN HC+BootstrapGenomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer
GSE25136_egf1520 - GSE25136 - SiGN-BN HC+BootstrapOptimizing molecular signatures for prostate cancer recurrence
GSE25428_egf1520 - GSE25428 - SiGN-BN HC+BootstrapGene expression profiles of ovarian cancer cell lines in the presence and absence of a DNA methyltransferase inhibitor
GSE2549_egf1520 - GSE2549 - SiGN-BN HC+BootstrapMalignant pleural mesothelioma
GSE2603_egf1520 - GSE2603 - SiGN-BN HC+BootstrapSubpopulations of MDA-MB-231 and Primary Breast Cancers
GSE26549_egf1520 - GSE26549 - SiGN-BN HC+BootstrapGene Expression Profiling Predicts the Development of Oral Cancer
GSE26599_egf1520 - GSE26599 - SiGN-BN HC+BootstrapGene expression profile in response to doxorubicin-rapamycin combined treatment of HER-2 overexpressing human mammary epithelial cell lines
GSE26639_egf1520 - GSE26639 - SiGN-BN HC+BootstrapExpression Data from 226 patients of the REMAGUS02 trial
GSE26712_egf1520 - GSE26712 - SiGN-BN HC+BootstrapA Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer
GSE26906_egf1520 - GSE26906 - SiGN-BN HC+BootstrapAPC colon stage II
GSE27155_egf1520 - GSE27155 - SiGN-BN HC+BootstrapHuman thyroid adenomas, carcinomas, and normals
GSE27480_egf1520 - GSE27480 - SiGN-BN HC+BootstrapGene-expression analysis of Oncostatin-M (OSM) signalling in cervical squamous cell carcinomas over-expressing the Oncostatin-M receptor (OSMR)
GSE27562_egf1520 - GSE27562 - SiGN-BN HC+BootstrapExpression data from human PBMCs from breast cancer patients and controls
GSE2841_egf1520 - GSE2841 - SiGN-BN HC+BootstrapExpression Profiling of pheochromocytomas of various genetic origins
GSE28497_egf1520 - GSE28497 - SiGN-BN HC+BootstrapNew markers for minimal residual disease detection in acute lymphoblastic leukemia
GSE28821_egf1520 - GSE28821 - SiGN-BN HC+BootstrapLaser-capture microdissected invasive micropapillary carcinomas of the breast
GSE29013_egf1520 - GSE29013 - SiGN-BN HC+BootstrapRobust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non-Small-Cell Lung Cancer Patients
GSE2912_egf1520 - GSE2912 - SiGN-BN HC+BootstrapMolecular classification of multiple myeloma
GSE29288_egf1520 - GSE29288 - SiGN-BN HC+BootstrapComparison between cell lines from 9 different cancer tissue (NCI-60) (Agilent WG platform)
GSE29354_egf1520 - GSE29354 - SiGN-BN HC+BootstrapMesothelioma tumor gene expression profiles
GSE29598_egf1520 - GSE29598 - SiGN-BN HC+BootstrapA Methodology for Utilization of Predictive Genomic Signatures in FFPE Samples
GSE29683_egf1520 - GSE29683 - SiGN-BN HC+BootstrapCoexpression of Normally Incompatible Developmental Pathways in Retinoblastoma Genesis [human tumor/cell line data]
GSE29817_egf1520 - GSE29817 - SiGN-BN HC+BootstrapMembranous Expression of Ectodomain Isoforms of the Epidermal Growth Factor Receptor (EGFR) Predicts Outcome after Chemoradiotherapy of Lymph Node Negative Cervical Cancer
GSE2990_egf1520 - GSE2990 - SiGN-BN HC+BootstrapGene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
GSE30240_egf1520 - GSE30240 - SiGN-BN HC+BootstrapExpression data from 5 human cell lines exposed to IR (5 Gy)
GSE30375_egf1520 - GSE30375 - SiGN-BN HC+BootstrapGene expression data from sorted and unsorted primary human acute myeloid leukemia (AML) samples
GSE30784_egf1520 - GSE30784 - SiGN-BN HC+BootstrapGene expression profiling of oral squamous cell carcinoma (OSCC)
GSE30929_egf1520 - GSE30929 - SiGN-BN HC+BootstrapWhole-transcript expression data for liposarcoma
GSE31245_egf1520 - GSE31245 - SiGN-BN HC+BootstrapUnique gene expression profile based upon pathologic response in epithelial ovarian cancer
GSE31279_egf1520 - GSE31279 - SiGN-BN HC+BootstrapDecoding differentially regulated epithelial and stromal pathways in colorectal cancer
GSE3141_egf1520 - GSE3141 - SiGN-BN HC+BootstrapLung Cancer Dataset
GSE3143_egf1520 - GSE3143 - SiGN-BN HC+BootstrapBreast Cancer Dataset
GSE3149_egf1520 - GSE3149 - SiGN-BN HC+BootstrapOvarian Cancer Dataset
GSE3151_egf1520 - GSE3151 - SiGN-BN HC+BootstrapOncogene Signature Dataset
GSE31519_egf1520 - GSE31519 - SiGN-BN HC+BootstrapA Clinically Relevant Gene Signature in Triple-Negative and Basal-Like Breast Cancer
GSE31547_egf1520 - GSE31547 - SiGN-BN HC+BootstrapMSKCC-A Primary Lung Cancer Specimens
GSE31548_egf1520 - GSE31548 - SiGN-BN HC+BootstrapMSKCC-B Primary Lung Cancer Specimens
GSE31552_egf1520 - GSE31552 - SiGN-BN HC+BootstrapExpression Data from human Lung tissue of Patients with Non Small Cell Lung Cancer (NSCLC)
GSE3167_egf1520 - GSE3167 - SiGN-BN HC+BootstrapClassification of carcinoma in situ lesions in human bladder cancer
GSE32269_egf1520 - GSE32269 - SiGN-BN HC+BootstrapExpression data for primary localized prostate cancer versus castration-resistant bone metastatic prostate cancer
GSE32448_egf1520 - GSE32448 - SiGN-BN HC+BootstrapCPDR tumor-benign 80 genechip dataset
GSE32474_egf1520 - GSE32474 - SiGN-BN HC+BootstrapComparison between cell lines from 9 different cancer tissue (NCI-60) (Affymetrix U133 Plus 2.0)
GSE3593_egf1520 - GSE3593 - SiGN-BN HC+BootstrapGenomic approach to refine prognosis for adjuvant therapy in early stage non-small cell lung carcinoma
GSE3629_egf1520 - GSE3629 - SiGN-BN HC+BootstrapMolecular Marker for predicting development of cancer in ulcerative colitis
GSE3726_egf1520 - GSE3726 - SiGN-BN HC+BootstrapPrognostic gene signatures can be measured with samples stored in RNAlater
GSE3960_egf1520 - GSE3960 - SiGN-BN HC+BootstrapClassification of neuroblastoma by integrating gene expression pattern with regional alterations in DNA copy number
GSE4115_egf1520 - GSE4115 - SiGN-BN HC+BootstrapAirway Epithelial Gene Expression Diagnostic for the Evaluation of Smokers with Suspect Lung Cancer
GSE4122_egf1520 - GSE4122 - SiGN-BN HC+BootstrapGene Expression Analysis of Ovarian Samples
GSE4183_egf1520 - GSE4183 - SiGN-BN HC+BootstrapInflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature
GSE4290_egf1520 - GSE4290 - SiGN-BN HC+BootstrapExpression data of glioma samples from Henry Ford Hospital
GSE4452_egf1520 - GSE4452 - SiGN-BN HC+BootstrapGene Expression Profiles of Multiple Myeloma (N=65) Before Treatment
GSE4459_egf1520 - GSE4459 - SiGN-BN HC+BootstrapGene expression signature and the prediction of lymph node metastases
GSE4536_egf1520 - GSE4536 - SiGN-BN HC+BootstrapTumor stem cells more closely mirror the phenotype and genotype of primary human tumors than do cancer cell lines
GSE4554_egf1520 - GSE4554 - SiGN-BN HC+BootstrapGene expression signature of colorectal cancer with microsatellite instability.
GSE4573_egf1520 - GSE4573 - SiGN-BN HC+BootstrapGene expression signatures for predicting prognosis of squamous cell lung carcinomas
GSE4581_egf1520 - GSE4581 - SiGN-BN HC+BootstrapGene Expression Profiles of Multiple Myeloma (N=414) Before Treatment
GSE4823_egf1520 - GSE4823 - SiGN-BN HC+BootstrapComparison of normal breast epithelium and stroma from reduction and I.D.C. cases
GSE5107_egf1520 - GSE5107 - SiGN-BN HC+BootstrapDistinct Transcription Profiles of Primary and Secondary Glioblastomas
GSE5206_egf1520 - GSE5206 - SiGN-BN HC+BootstrapLarge-scale deployment of embryonic gene programming in human and murine colon cancer: a new target for intervention.
GSE5327_egf1520 - GSE5327 - SiGN-BN HC+BootstrapBreast cancer relapse free survival and lung metastasis free survival
GSE5364_egf1520 - GSE5364 - SiGN-BN HC+BootstrapA Precisely Regulated Gene Expression Cassette Potently Modulates Metastasis and Survival in Multiple Solid Cancers
GSE5460_egf1520 - GSE5460 - SiGN-BN HC+BootstrapPredicting Features of Breast Cancer with Gene Expression Patterns
GSE5462_egf1520 - GSE5462 - SiGN-BN HC+BootstrapLetrozole (Femara) early response to treatment
GSE5846_egf1520 - GSE5846 - SiGN-BN HC+BootstrapNCI-60 Cancer Cell Line
GSE5847_egf1520 - GSE5847 - SiGN-BN HC+BootstrapTumor and stroma from breast by LCM
GSE5851_egf1520 - GSE5851 - SiGN-BN HC+BootstrapPhase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC
GSE5900_egf1520 - GSE5900 - SiGN-BN HC+BootstrapGene Expression of Bone Marrow Plasma Cells from Healthy Donors (N=22), MGUS (N=44), and Smoldering Myeloma (N=12)
GSE6008_egf1520 - GSE6008 - SiGN-BN HC+BootstrapHuman ovarian tumors and normal ovaries
GSE6338_egf1520 - GSE6338 - SiGN-BN HC+BootstrapGene expression analysis of Peripheral T-cell Lymphoma/Unspecified
GSE6365_egf1520 - GSE6365 - SiGN-BN HC+BootstrapDistinct transcriptional and genetic features associated with chromosome 13 deletion in multiple myeloma
GSE6401_egf1520 - GSE6401 - SiGN-BN HC+BootstrapUp-regulation of translational machinery and distinct genetic subgroups characterize hyperdiploidy in multiple myeloma
GSE6462_egf1520 - GSE6462 - SiGN-BN HC+BootstrapMCF7 dose response
GSE6465_egf1520 - GSE6465 - SiGN-BN HC+BootstrapExpression data of Hepatocellular Carcinoma
GSE6477_egf1520 - GSE6477 - SiGN-BN HC+BootstrapExpression data from different stages of plasma cell neoplasm
GSE6481_egf1520 - GSE6481 - SiGN-BN HC+BootstrapGene Expression Analysis of Soft Tissue Sarcomas: Characterization & Reclassification of Malignant Fibrous Histiocytoma
GSE6691_egf1520 - GSE6691 - SiGN-BN HC+BootstrapGene expression profiling of B lymphocytes and plasma cells from WaldenstrÖm’s macroglobulinemia.
GSE6764_egf1520 - GSE6764 - SiGN-BN HC+BootstrapGenome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma
GSE6791_egf1520 - GSE6791 - SiGN-BN HC+BootstrapGene Expression Profiles of HPV-Positive and -Negative Head/Neck and Cervical Cancers
GSE6956_egf1520 - GSE6956 - SiGN-BN HC+BootstrapTumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men
GSE7208_egf1520 - GSE7208 - SiGN-BN HC+BootstrapExpression data from 59 human colon tumor tissue samples
GSE7390_egf1520 - GSE7390 - SiGN-BN HC+BootstrapStrong Time Dependence of the 76-Gene Prognostic Signature
GSE7553_egf1520 - GSE7553 - SiGN-BN HC+BootstrapGene Expression Patterns Involved in the Malignant Transformation and Progression of Metastatic Melanoma
GSE7604_egf1520 - GSE7604 - SiGN-BN HC+BootstrapHuman Colon tumor vs Normal Human DNA
GSE7606_egf1520 - GSE7606 - SiGN-BN HC+BootstrapHuman Melanoma vs Normal Human DNA
GSE7670_egf1520 - GSE7670 - SiGN-BN HC+BootstrapExpression data from Lung cancer
GSE7696_egf1520 - GSE7696 - SiGN-BN HC+BootstrapGlioblastoma from a homogenous cohort of patients treated within clinical trial
GSE7849_egf1520 - GSE7849 - SiGN-BN HC+BootstrapAge-Specific Differences of Oncogenic Pathway Deregulation Seen in Human Breast Tumors
GSE7904_egf1520 - GSE7904 - SiGN-BN HC+BootstrapExpression data from human breast tissue
GSE8057_egf1520 - GSE8057 - SiGN-BN HC+BootstrapExpression data from ovarian cancer cells with time-course and concentration-profiles
GSE8139_egf1520 - GSE8139 - SiGN-BN HC+BootstrapExpression data from MCF7/HER2-18 xenografts
GSE8141_egf1520 - GSE8141 - SiGN-BN HC+BootstrapExpression data from MCF7 wt and MCF7/HER2-18 xenografts
GSE8218_egf1520 - GSE8218 - SiGN-BN HC+BootstrapGene expression data from prostate cancer samples
GSE8332_egf1520 - GSE8332 - SiGN-BN HC+BootstrapDeath receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL
GSE8401_egf1520 - GSE8401 - SiGN-BN HC+BootstrapGene Signature for Aggression of Melanoma Metastases - Melanoma Metastasis
GSE8481_egf1520 - GSE8481 - SiGN-BN HC+BootstrapVarious human cell types
GSE8546_egf1520 - GSE8546 - SiGN-BN HC+BootstrapGene Expression Changes in Myeloma Cells Following Short Term In-vivo Drug Exposure
GSE8581_egf1520 - GSE8581 - SiGN-BN HC+BootstrapHuman Chronic Obstructive Pulmonary Disorder (COPD) Biomarker
GSE8671_egf1520 - GSE8671 - SiGN-BN HC+BootstrapTranscriptome profile of human colorectal adenomas.
GSE8835_egf1520 - GSE8835 - SiGN-BN HC+BootstrapChronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells.
GSE8894_egf1520 - GSE8894 - SiGN-BN HC+BootstrapPrediction of Recurrence-Free Survival in Postoperative NSCLC Patients—a Useful Prospective Clinical Practice
GSE9014_egf1520 - GSE9014 - SiGN-BN HC+BootstrapTumor-associated stroma derived from primary clinical breast cancer samples
GSE9169_egf1520 - GSE9169 - SiGN-BN HC+BootstrapGene expression during neuronal differentiation in two subtypes of SH-SY5Y
GSE9195_egf1520 - GSE9195 - SiGN-BN HC+BootstrapPredicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
GSE9309_egf1520 - GSE9309 - SiGN-BN HC+BootstrapRecovery of biological information under heterogeneous experimental conditions using subgroup standardization.
GSE9348_egf1520 - GSE9348 - SiGN-BN HC+BootstrapExpression data from healthy controls and early stage CRC patient's tumor
GSE9750_egf1520 - GSE9750 - SiGN-BN HC+BootstrapIdentification of gene expression profiles in cervical cancer
GSE9843_egf1520 - GSE9843 - SiGN-BN HC+BootstrapGene expression profiling of 91 hepatocellular carcinomas with hepatitis C virus etiology
GSE9936_egf1520 - GSE9936 - SiGN-BN HC+BootstrapExpression data from human breast cancer cells (MCF-7) coexpressing ERalpha and Erbeta, treated with phytoestrogens
GSE9992_egf1520 - GSE9992 - SiGN-BN HC+BootstrapMolecular and transcriptional characterization of chromosome 17p loss in chronic lymphocytic leukemia, experiment A